Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tal1
|
ENSMUSG00000028717.6 | T cell acute lymphocytic leukemia 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_115048309_115048475 | Tal1 | 8034 | 0.155966 | 0.95 | 3.7e-28 | Click! |
chr4_115059412_115059621 | Tal1 | 8 | 0.972150 | 0.92 | 2.6e-23 | Click! |
chr4_115056446_115056861 | Tal1 | 227 | 0.915348 | 0.92 | 8.8e-23 | Click! |
chr4_115047820_115048056 | Tal1 | 8488 | 0.154697 | 0.92 | 1.3e-22 | Click! |
chr4_115057189_115057563 | Tal1 | 62 | 0.967778 | 0.89 | 8.4e-20 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_29815389_29815572 | 284.38 |
Eml6 |
echinoderm microtubule associated protein like 6 |
6182 |
0.16 |
chr11_32245695_32246028 | 256.32 |
Nprl3 |
nitrogen permease regulator-like 3 |
4317 |
0.12 |
chr7_80208686_80209443 | 251.95 |
Gm45206 |
predicted gene 45206 |
330 |
0.78 |
chr12_88984393_88984775 | 242.12 |
Nrxn3 |
neurexin III |
31185 |
0.23 |
chr14_46539820_46540205 | 234.50 |
E130120K24Rik |
RIKEN cDNA E130120K24 gene |
16291 |
0.12 |
chr5_23922914_23923135 | 230.92 |
Fam126a |
family with sequence similarity 126, member A |
120 |
0.95 |
chr11_31831386_31831912 | 225.58 |
Gm12107 |
predicted gene 12107 |
1011 |
0.55 |
chr6_67161663_67162061 | 224.57 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr3_30765691_30766002 | 222.91 |
Samd7 |
sterile alpha motif domain containing 7 |
9624 |
0.14 |
chr8_105820906_105821324 | 222.88 |
Ranbp10 |
RAN binding protein 10 |
6090 |
0.09 |
chr12_110974333_110974713 | 219.76 |
Ankrd9 |
ankyrin repeat domain 9 |
3732 |
0.14 |
chr16_56071732_56071993 | 217.92 |
Gm24047 |
predicted gene, 24047 |
1299 |
0.31 |
chr6_70727412_70727666 | 217.52 |
Igkj5 |
immunoglobulin kappa joining 5 |
3653 |
0.15 |
chrX_162679005_162679180 | 215.81 |
Gm15203 |
predicted gene 15203 |
85 |
0.96 |
chr15_93372828_93373012 | 215.48 |
Zcrb1 |
zinc finger CCHC-type and RNA binding motif 1 |
15224 |
0.16 |
chr15_103251687_103251873 | 214.16 |
Nfe2 |
nuclear factor, erythroid derived 2 |
93 |
0.94 |
chr5_52712758_52713046 | 212.97 |
Pi4k2b |
phosphatidylinositol 4-kinase type 2 beta |
28672 |
0.15 |
chr12_76673740_76674235 | 212.30 |
Sptb |
spectrin beta, erythrocytic |
36036 |
0.15 |
chr4_134981994_134982157 | 209.96 |
Syf2 |
SYF2 homolog, RNA splicing factor (S. cerevisiae) |
51065 |
0.11 |
chr15_97379586_97379766 | 209.25 |
Pced1b |
PC-esterase domain containing 1B |
18459 |
0.24 |
chr13_101611824_101612000 | 208.50 |
Gm29341 |
predicted gene 29341 |
5679 |
0.22 |
chr11_102365077_102365683 | 206.30 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
100 |
0.94 |
chr8_23054025_23054342 | 205.66 |
Ank1 |
ankyrin 1, erythroid |
4076 |
0.2 |
chr6_58642386_58642566 | 204.93 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
1894 |
0.39 |
chr1_33630885_33631502 | 204.42 |
Prim2 |
DNA primase, p58 subunit |
7869 |
0.14 |
chr15_5658919_5659100 | 204.30 |
Gm18715 |
predicted gene, 18715 |
55025 |
0.14 |
chr1_127756612_127756781 | 204.29 |
Acmsd |
amino carboxymuconate semialdehyde decarboxylase |
61 |
0.97 |
chr13_95679618_95679929 | 204.09 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
2551 |
0.2 |
chr5_22348437_22348700 | 203.29 |
Reln |
reelin |
3866 |
0.17 |
chr14_32146198_32146521 | 202.80 |
Msmb |
beta-microseminoprotein |
1228 |
0.33 |
chr18_32542304_32542816 | 201.13 |
Gypc |
glycophorin C |
7142 |
0.21 |
chr1_55946905_55947229 | 200.96 |
Gm36986 |
predicted gene, 36986 |
13689 |
0.22 |
chr11_4553637_4553951 | 199.96 |
Mtmr3 |
myotubularin related protein 3 |
7526 |
0.17 |
chr13_83344551_83344924 | 198.52 |
Gm48156 |
predicted gene, 48156 |
155028 |
0.04 |
chr10_11323594_11323775 | 197.08 |
Gm48666 |
predicted gene, 48666 |
6731 |
0.15 |
chr12_111517954_111518283 | 196.45 |
Gm40578 |
predicted gene, 40578 |
17278 |
0.1 |
chrX_140953732_140953903 | 196.24 |
Psmd10 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 |
2872 |
0.24 |
chr19_60386923_60387224 | 195.56 |
Prlhr |
prolactin releasing hormone receptor |
81231 |
0.09 |
chr15_80910888_80911184 | 193.87 |
Tnrc6b |
trinucleotide repeat containing 6b |
4880 |
0.17 |
chr14_60654080_60654264 | 193.53 |
Spata13 |
spermatogenesis associated 13 |
19417 |
0.21 |
chr16_48252848_48253236 | 193.38 |
Gm49770 |
predicted gene, 49770 |
8772 |
0.18 |
chr7_99594452_99594625 | 192.73 |
Arrb1 |
arrestin, beta 1 |
55 |
0.96 |
chr13_20150160_20150481 | 191.86 |
Elmo1 |
engulfment and cell motility 1 |
34887 |
0.21 |
chr5_96951661_96952003 | 190.58 |
Gm43144 |
predicted gene 43144 |
11535 |
0.1 |
chr15_93372582_93372767 | 189.69 |
Zcrb1 |
zinc finger CCHC-type and RNA binding motif 1 |
15470 |
0.16 |
chr7_115830920_115831237 | 189.44 |
Sox6 |
SRY (sex determining region Y)-box 6 |
6368 |
0.31 |
chr15_34983305_34983512 | 189.19 |
Stk3 |
serine/threonine kinase 3 |
16514 |
0.26 |
chr12_76670569_76670894 | 189.05 |
Sptb |
spectrin beta, erythrocytic |
39292 |
0.14 |
chr5_151418628_151418887 | 188.04 |
Gm42906 |
predicted gene 42906 |
9406 |
0.16 |
chr7_75830381_75830681 | 186.53 |
Klhl25 |
kelch-like 25 |
17779 |
0.18 |
chr6_148603565_148603734 | 184.94 |
Gm6313 |
predicted gene 6313 |
6084 |
0.21 |
chr14_63062234_63062642 | 183.78 |
Defb42 |
defensin beta 42 |
7365 |
0.12 |
chr8_128688649_128689204 | 182.55 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
3056 |
0.24 |
chr11_117797537_117797802 | 182.43 |
6030468B19Rik |
RIKEN cDNA 6030468B19 gene |
9 |
0.94 |
chr2_181419480_181419646 | 182.11 |
Zbtb46 |
zinc finger and BTB domain containing 46 |
4825 |
0.11 |
chr2_164760159_164760320 | 181.81 |
Dnttip1 |
deoxynucleotidyltransferase, terminal, interacting protein 1 |
6100 |
0.08 |
chr3_116859439_116859612 | 181.19 |
Frrs1 |
ferric-chelate reductase 1 |
42 |
0.96 |
chr10_95569556_95569732 | 179.81 |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
5498 |
0.14 |
chr2_121037044_121037214 | 179.77 |
Epb42 |
erythrocyte membrane protein band 4.2 |
57 |
0.95 |
chr2_28602260_28602441 | 179.06 |
Gm22824 |
predicted gene, 22824 |
5845 |
0.11 |
chr18_77704753_77705042 | 179.06 |
8030462N17Rik |
RIKEN cDNA 8030462N17 gene |
9036 |
0.14 |
chr13_95671451_95671789 | 178.93 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
101 |
0.96 |
chr2_158141871_158142558 | 178.42 |
Tgm2 |
transglutaminase 2, C polypeptide |
2478 |
0.23 |
chr1_157695278_157695646 | 178.32 |
Gm38213 |
predicted gene, 38213 |
73326 |
0.09 |
chrX_101287598_101287912 | 178.25 |
Med12 |
mediator complex subunit 12 |
1731 |
0.2 |
chr7_123462053_123462460 | 176.40 |
Aqp8 |
aquaporin 8 |
35 |
0.98 |
chr7_128854662_128855004 | 176.38 |
Gm25778 |
predicted gene, 25778 |
28486 |
0.15 |
chr5_96989015_96989192 | 175.81 |
Gm9484 |
predicted gene 9484 |
8261 |
0.13 |
chr9_58657759_58658148 | 175.36 |
Rec114 |
REC114 meiotic recombination protein |
1339 |
0.42 |
chr7_133698079_133698264 | 175.05 |
Uros |
uroporphyrinogen III synthase |
91 |
0.95 |
chr4_93481257_93481600 | 174.65 |
Gm23443 |
predicted gene, 23443 |
63849 |
0.13 |
chr8_120371766_120372131 | 174.44 |
Gm22715 |
predicted gene, 22715 |
71601 |
0.09 |
chr7_120875272_120875461 | 174.35 |
Gm15774 |
predicted gene 15774 |
68 |
0.93 |
chr8_122286979_122287274 | 174.26 |
Zfpm1 |
zinc finger protein, multitype 1 |
4985 |
0.17 |
chr4_151960522_151960830 | 174.18 |
Dnajc11 |
DnaJ heat shock protein family (Hsp40) member C11 |
3533 |
0.16 |
chr13_59814367_59814542 | 173.37 |
Tut7 |
terminal uridylyl transferase 7 |
4948 |
0.12 |
chr19_32476101_32476290 | 173.33 |
Minpp1 |
multiple inositol polyphosphate histidine phosphatase 1 |
9574 |
0.14 |
chr5_115267246_115267406 | 172.20 |
Gm13831 |
predicted gene 13831 |
4233 |
0.09 |
chr17_83651316_83651614 | 171.87 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
19570 |
0.22 |
chr11_105366062_105366358 | 171.87 |
Gm11638 |
predicted gene 11638 |
2958 |
0.23 |
chr11_102363647_102363997 | 171.79 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
118 |
0.93 |
chr15_62159095_62159287 | 171.42 |
Pvt1 |
Pvt1 oncogene |
18984 |
0.25 |
chr11_31861192_31861524 | 171.30 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
10853 |
0.19 |
chr6_38341755_38341991 | 171.20 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
12400 |
0.13 |
chr4_46854042_46854371 | 171.13 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
5696 |
0.29 |
chr7_100844413_100844706 | 170.99 |
Relt |
RELT tumor necrosis factor receptor |
10870 |
0.14 |
chr14_69318389_69318982 | 170.57 |
Gm16677 |
predicted gene, 16677 |
18397 |
0.08 |
chr10_62342649_62342920 | 170.53 |
Hk1 |
hexokinase 1 |
62 |
0.96 |
chr3_19650569_19650855 | 170.32 |
Trim55 |
tripartite motif-containing 55 |
6204 |
0.16 |
chr17_48272064_48272554 | 170.19 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
130 |
0.94 |
chr5_149649169_149649529 | 169.99 |
Gm20005 |
predicted gene, 20005 |
7739 |
0.14 |
chr8_33734991_33735310 | 169.84 |
Gtf2e2 |
general transcription factor II E, polypeptide 2 (beta subunit) |
1707 |
0.27 |
chr15_56623570_56623885 | 169.81 |
Has2os |
hyaluronan synthase 2, opposite strand |
66217 |
0.12 |
chr16_12697258_12697682 | 169.47 |
Gm38619 |
predicted gene, 38619 |
6898 |
0.28 |
chr17_25089285_25089469 | 169.42 |
Ift140 |
intraflagellar transport 140 |
1294 |
0.29 |
chr15_78922683_78922995 | 169.07 |
Lgals1 |
lectin, galactose binding, soluble 1 |
3886 |
0.09 |
chr10_63272949_63273252 | 169.03 |
Gm47615 |
predicted gene, 47615 |
3010 |
0.16 |
chr18_61960597_61960886 | 168.76 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
7657 |
0.21 |
chr13_99108120_99108286 | 168.72 |
Gm807 |
predicted gene 807 |
7442 |
0.18 |
chr19_6132479_6132770 | 168.47 |
Snx15 |
sorting nexin 15 |
4320 |
0.07 |
chr16_36062065_36062536 | 168.35 |
Fam162a |
family with sequence similarity 162, member A |
9069 |
0.11 |
chr3_84772122_84772299 | 168.13 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
43058 |
0.17 |
chr2_119605466_119605626 | 168.05 |
Oip5os1 |
Opa interacting protein 5, opposite strand 1 |
11243 |
0.1 |
chr6_86077923_86078088 | 167.91 |
Add2 |
adducin 2 (beta) |
52 |
0.96 |
chr9_124138054_124138419 | 167.58 |
Ccr5 |
chemokine (C-C motif) receptor 5 |
9488 |
0.21 |
chr1_43414347_43414515 | 167.47 |
Gm29041 |
predicted gene 29041 |
4847 |
0.23 |
chr10_17590195_17590550 | 167.15 |
Gm47770 |
predicted gene, 47770 |
63458 |
0.1 |
chr3_103196500_103196848 | 166.97 |
2410024N13Rik |
RIKEN cDNA 2410024N13 gene |
2301 |
0.22 |
chr5_147441974_147442285 | 166.42 |
Gm42883 |
predicted gene 42883 |
2739 |
0.14 |
chr5_105565875_105566288 | 166.08 |
Lrrc8c |
leucine rich repeat containing 8 family, member C |
7223 |
0.2 |
chr10_41209082_41209401 | 165.81 |
Gm25526 |
predicted gene, 25526 |
6804 |
0.21 |
chr8_123988622_123988985 | 165.08 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
5681 |
0.11 |
chr11_4543369_4543542 | 165.07 |
Mtmr3 |
myotubularin related protein 3 |
2813 |
0.24 |
chr14_69304834_69305018 | 164.55 |
Synb |
syncytin b |
10627 |
0.09 |
chr14_69523086_69523268 | 164.54 |
Gm27179 |
predicted gene 27179 |
10628 |
0.1 |
chr8_68606713_68606995 | 163.86 |
Gm15654 |
predicted gene 15654 |
13284 |
0.25 |
chr4_93583749_93583913 | 163.70 |
Gm12640 |
predicted gene 12640 |
15355 |
0.19 |
chr9_64044981_64045602 | 163.42 |
Gm25606 |
predicted gene, 25606 |
3205 |
0.17 |
chr18_21283772_21283949 | 163.34 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
16263 |
0.17 |
chr19_17323425_17323682 | 162.97 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
11883 |
0.21 |
chr14_47522434_47522734 | 162.78 |
Fbxo34 |
F-box protein 34 |
3495 |
0.15 |
chr2_28598073_28598473 | 162.75 |
Gm22675 |
predicted gene, 22675 |
3146 |
0.14 |
chr1_161894692_161894863 | 162.44 |
Gm31925 |
predicted gene, 31925 |
2630 |
0.23 |
chr10_93143358_93143676 | 162.38 |
Cdk17 |
cyclin-dependent kinase 17 |
17358 |
0.17 |
chr17_84776723_84776893 | 162.10 |
Lrpprc |
leucine-rich PPR-motif containing |
735 |
0.64 |
chr15_73212141_73212465 | 161.92 |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
2812 |
0.25 |
chr3_108096711_108096990 | 161.70 |
Gnat2 |
guanine nucleotide binding protein, alpha transducing 2 |
393 |
0.71 |
chr4_109445455_109445982 | 161.34 |
Ttc39a |
tetratricopeptide repeat domain 39A |
24776 |
0.14 |
chr5_120136253_120136600 | 161.06 |
Gm10390 |
predicted gene 10390 |
2835 |
0.27 |
chr16_34031697_34031893 | 160.93 |
Kalrn |
kalirin, RhoGEF kinase |
15301 |
0.19 |
chr1_191855569_191855746 | 160.69 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
28509 |
0.11 |
chr2_103893863_103894037 | 160.47 |
Gm13876 |
predicted gene 13876 |
5626 |
0.13 |
chr3_144670267_144670456 | 159.90 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
27106 |
0.13 |
chr3_127889681_127889845 | 159.83 |
Fam241a |
family with sequence similarity 241, member A |
6525 |
0.13 |
chr7_103877202_103877483 | 159.50 |
Olfr66 |
olfactory receptor 66 |
4899 |
0.07 |
chr16_90988770_90988947 | 159.44 |
Gm15965 |
predicted gene 15965 |
4951 |
0.12 |
chr5_75460472_75460800 | 159.32 |
Gm42800 |
predicted gene 42800 |
61264 |
0.11 |
chr18_15345573_15345724 | 159.23 |
A830021F12Rik |
RIKEN cDNA A830021F12 gene |
6286 |
0.21 |
chr15_36321999_36322330 | 158.60 |
Rpl7a-ps3 |
ribosomal protein L7A, pseudogene 3 |
13220 |
0.12 |
chr15_83423666_83423948 | 158.49 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
17 |
0.97 |
chr14_45653782_45654098 | 158.30 |
Ddhd1 |
DDHD domain containing 1 |
3420 |
0.14 |
chr18_34516209_34516494 | 158.25 |
n-R5s24 |
nuclear encoded rRNA 5S 24 |
6614 |
0.15 |
chr9_22453602_22453960 | 158.19 |
Gm17545 |
predicted gene, 17545 |
509 |
0.68 |
chr4_24644850_24645009 | 157.88 |
Klhl32 |
kelch-like 32 |
30498 |
0.21 |
chr2_167043430_167043751 | 157.72 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
95 |
0.93 |
chr14_47321701_47321992 | 157.38 |
Gm49190 |
predicted gene, 49190 |
790 |
0.44 |
chr4_116193969_116194265 | 157.24 |
Llph-ps1 |
LLP homolog, pseudogene 1 |
6835 |
0.1 |
chr9_43234311_43234858 | 156.87 |
Oaf |
out at first homolog |
5327 |
0.16 |
chr6_5291230_5291963 | 156.62 |
Pon2 |
paraoxonase 2 |
2528 |
0.26 |
chr18_25097087_25097280 | 156.45 |
Fhod3 |
formin homology 2 domain containing 3 |
27178 |
0.22 |
chr6_70730875_70731236 | 156.03 |
Igkj5 |
immunoglobulin kappa joining 5 |
7169 |
0.13 |
chr13_99019946_99020104 | 155.89 |
A930014D07Rik |
RIKEN cDNA A930014D07 gene |
12926 |
0.12 |
chr1_58954126_58954299 | 155.62 |
Trak2 |
trafficking protein, kinesin binding 2 |
7875 |
0.16 |
chr16_97006668_97006833 | 155.46 |
Gm32432 |
predicted gene, 32432 |
87993 |
0.09 |
chr1_154033942_154034127 | 155.22 |
Gm28286 |
predicted gene 28286 |
267 |
0.91 |
chr9_14369323_14369628 | 155.16 |
Endod1 |
endonuclease domain containing 1 |
11508 |
0.12 |
chr2_33843200_33843519 | 155.00 |
Nron |
non-protein coding RNA, repressor of NFAT |
37500 |
0.15 |
chr11_121239715_121240038 | 154.72 |
Narf |
nuclear prelamin A recognition factor |
2623 |
0.17 |
chr17_33713331_33713621 | 153.97 |
Marchf2 |
membrane associated ring-CH-type finger 2 |
95 |
0.94 |
chr12_55051961_55052112 | 153.90 |
2700097O09Rik |
RIKEN cDNA 2700097O09 gene |
2065 |
0.2 |
chr16_31598355_31598677 | 153.85 |
Gm34256 |
predicted gene, 34256 |
5296 |
0.18 |
chr4_148204076_148204384 | 153.78 |
Fbxo2 |
F-box protein 2 |
43609 |
0.08 |
chr3_131728746_131728905 | 153.07 |
Gm29865 |
predicted gene, 29865 |
30980 |
0.22 |
chr16_91441869_91442151 | 153.01 |
Gm46562 |
predicted gene, 46562 |
16411 |
0.09 |
chr9_67024874_67025223 | 152.87 |
Tpm1 |
tropomyosin 1, alpha |
7777 |
0.18 |
chr4_109411064_109411374 | 152.72 |
Ttc39a |
tetratricopeptide repeat domain 39A |
3557 |
0.19 |
chr15_82184037_82184673 | 152.56 |
Gm49502 |
predicted gene, 49502 |
1161 |
0.29 |
chr10_100574875_100575154 | 152.52 |
Gm47956 |
predicted gene, 47956 |
2412 |
0.2 |
chr10_42265100_42265393 | 152.38 |
Foxo3 |
forkhead box O3 |
6880 |
0.27 |
chr11_85339500_85339819 | 152.33 |
Bcas3 |
breast carcinoma amplified sequence 3 |
13508 |
0.19 |
chr4_59533305_59533500 | 152.30 |
Gm12529 |
predicted gene 12529 |
655 |
0.67 |
chr4_42867543_42867734 | 152.09 |
Fam205c |
family with sequence similarity 205, member C |
6083 |
0.14 |
chr1_73072668_73072833 | 151.88 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
48181 |
0.15 |
chr12_80778227_80778545 | 151.56 |
Gm47941 |
predicted gene, 47941 |
11957 |
0.12 |
chr12_111443494_111443821 | 151.29 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
667 |
0.58 |
chr7_127767294_127767484 | 151.15 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
2426 |
0.11 |
chrX_164164755_164165040 | 151.01 |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
2719 |
0.26 |
chr11_95011990_95012348 | 150.97 |
Samd14 |
sterile alpha motif domain containing 14 |
1888 |
0.21 |
chr11_16503276_16503437 | 150.96 |
Sec61g |
SEC61, gamma subunit |
1688 |
0.39 |
chr19_8603137_8603306 | 150.96 |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
11932 |
0.1 |
chrX_85614770_85615135 | 150.75 |
Gm44378 |
predicted gene, 44378 |
25975 |
0.18 |
chr8_121899242_121899545 | 150.60 |
Slc7a5 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
2891 |
0.15 |
chr8_122309305_122309664 | 150.47 |
Zfpm1 |
zinc finger protein, multitype 1 |
2164 |
0.24 |
chr16_58454803_58455144 | 150.45 |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
218 |
0.94 |
chr9_64590624_64590805 | 150.36 |
Megf11 |
multiple EGF-like-domains 11 |
43815 |
0.17 |
chr14_69321815_69322332 | 150.09 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr14_69540059_69540582 | 150.04 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr19_37238054_37238331 | 149.96 |
Gm25268 |
predicted gene, 25268 |
4708 |
0.16 |
chr16_21996984_21997165 | 149.13 |
Liph |
lipase, member H |
1411 |
0.37 |
chr8_119918152_119918328 | 149.13 |
Usp10 |
ubiquitin specific peptidase 10 |
7383 |
0.17 |
chr13_75733796_75734110 | 149.04 |
Gm48302 |
predicted gene, 48302 |
6674 |
0.14 |
chr16_49800061_49800448 | 148.98 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
279 |
0.89 |
chr14_20599676_20599956 | 148.96 |
Usp54 |
ubiquitin specific peptidase 54 |
5514 |
0.13 |
chr3_102165876_102166166 | 148.90 |
Vangl1 |
VANGL planar cell polarity 1 |
81 |
0.96 |
chr6_29701091_29701386 | 148.81 |
Tspan33 |
tetraspanin 33 |
6790 |
0.18 |
chr13_44663056_44663676 | 148.76 |
Gm47805 |
predicted gene, 47805 |
41184 |
0.16 |
chr3_105808565_105808856 | 148.53 |
Gm5547 |
predicted gene 5547 |
6830 |
0.11 |
chr3_142884736_142884993 | 148.37 |
9530052C20Rik |
RIKEN cDNA 9530052C20 gene |
2369 |
0.19 |
chr7_100466963_100467472 | 148.33 |
Gm10603 |
predicted gene 10603 |
27 |
0.95 |
chr14_69536637_69537045 | 148.24 |
Gm27174 |
predicted gene 27174 |
18491 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
103.0 | 411.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
99.4 | 497.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
96.0 | 384.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
93.0 | 278.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
84.0 | 251.9 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
83.7 | 251.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
80.3 | 80.3 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
71.5 | 286.2 | GO:0008228 | opsonization(GO:0008228) |
66.9 | 133.8 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
65.2 | 260.9 | GO:0070836 | caveola assembly(GO:0070836) |
64.7 | 194.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
63.7 | 127.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
62.9 | 314.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
62.7 | 313.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
61.0 | 305.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
60.8 | 364.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
59.6 | 238.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
55.4 | 1164.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
55.4 | 277.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
54.7 | 218.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
54.0 | 161.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
53.3 | 266.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
53.2 | 159.6 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
52.8 | 211.1 | GO:0050904 | diapedesis(GO:0050904) |
52.6 | 262.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
51.5 | 463.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
50.9 | 458.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
50.6 | 101.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
49.8 | 199.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
48.2 | 96.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
46.7 | 186.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
46.0 | 138.0 | GO:0018343 | protein farnesylation(GO:0018343) |
46.0 | 229.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
45.5 | 182.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
45.3 | 45.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
45.3 | 90.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
45.2 | 135.7 | GO:0035973 | aggrephagy(GO:0035973) |
44.4 | 133.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
43.4 | 217.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
43.1 | 43.1 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
42.9 | 128.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
42.6 | 170.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
42.6 | 170.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
42.5 | 42.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
42.3 | 169.2 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
41.4 | 41.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
41.2 | 123.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
41.0 | 163.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
40.5 | 202.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
40.2 | 321.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
39.9 | 79.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
39.9 | 159.5 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
39.1 | 117.4 | GO:0070627 | ferrous iron import(GO:0070627) |
39.0 | 117.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
38.6 | 38.6 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
38.6 | 38.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
38.3 | 38.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
38.2 | 114.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
38.1 | 152.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
38.0 | 228.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
38.0 | 38.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
37.9 | 75.7 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
37.8 | 113.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
37.8 | 75.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
37.8 | 37.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
37.7 | 75.5 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
37.7 | 188.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
37.5 | 225.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
37.4 | 149.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
37.4 | 224.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
37.2 | 148.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
37.0 | 592.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
36.9 | 147.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
36.8 | 110.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
36.5 | 36.5 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
36.3 | 218.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
36.3 | 761.6 | GO:0048821 | erythrocyte development(GO:0048821) |
36.0 | 647.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
35.9 | 179.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
35.8 | 35.8 | GO:0007431 | salivary gland development(GO:0007431) |
35.4 | 176.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
35.4 | 106.1 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
35.1 | 105.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
35.0 | 70.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
34.5 | 137.9 | GO:0032264 | IMP salvage(GO:0032264) |
33.8 | 169.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
33.5 | 100.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
33.2 | 33.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
33.0 | 66.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
33.0 | 131.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
32.8 | 65.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
32.6 | 130.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
32.6 | 65.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
32.5 | 97.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
32.4 | 97.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
31.9 | 223.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
31.7 | 126.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
31.7 | 95.2 | GO:1903416 | response to glycoside(GO:1903416) |
31.7 | 95.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
31.7 | 95.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
31.7 | 158.4 | GO:0015879 | carnitine transport(GO:0015879) |
31.7 | 221.6 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
31.6 | 189.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
31.3 | 125.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
31.2 | 125.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
31.0 | 93.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
30.8 | 123.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
30.4 | 91.2 | GO:0001555 | oocyte growth(GO:0001555) |
30.2 | 120.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
29.8 | 89.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
29.7 | 89.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
29.6 | 118.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
29.4 | 29.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
29.3 | 117.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
29.1 | 58.2 | GO:0046618 | drug export(GO:0046618) |
28.8 | 86.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
28.8 | 86.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
28.7 | 286.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
28.6 | 57.1 | GO:0032898 | neurotrophin production(GO:0032898) |
28.5 | 85.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
28.4 | 85.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
28.3 | 84.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
28.2 | 140.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
27.8 | 111.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
27.7 | 110.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
27.4 | 109.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
27.3 | 136.7 | GO:0009642 | response to light intensity(GO:0009642) |
27.2 | 190.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
27.2 | 81.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
27.2 | 108.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
27.1 | 135.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
26.9 | 134.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
26.9 | 268.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
26.8 | 214.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
26.6 | 133.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
26.3 | 131.5 | GO:0015671 | oxygen transport(GO:0015671) |
26.1 | 52.1 | GO:0008050 | female courtship behavior(GO:0008050) |
26.0 | 78.1 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
25.9 | 51.8 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
25.9 | 103.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
25.5 | 25.5 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
25.4 | 25.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
25.3 | 151.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
25.2 | 100.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
25.1 | 50.2 | GO:0032782 | bile acid secretion(GO:0032782) |
25.1 | 75.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
25.1 | 225.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
25.0 | 224.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
24.9 | 99.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
24.8 | 99.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
24.8 | 49.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
24.7 | 74.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
24.7 | 49.4 | GO:0043379 | memory T cell differentiation(GO:0043379) |
24.7 | 24.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
24.6 | 49.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
24.4 | 97.8 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
24.4 | 73.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
24.4 | 73.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
24.2 | 48.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
24.2 | 169.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
24.0 | 24.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
24.0 | 383.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
23.9 | 95.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
23.7 | 47.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
23.7 | 71.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
23.6 | 94.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
23.5 | 70.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
23.3 | 419.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
23.3 | 69.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
23.2 | 139.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
23.1 | 46.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
23.0 | 69.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
23.0 | 344.7 | GO:0006828 | manganese ion transport(GO:0006828) |
22.9 | 45.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
22.9 | 22.9 | GO:0044532 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
22.5 | 67.4 | GO:0061511 | centriole elongation(GO:0061511) |
22.5 | 67.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
22.4 | 44.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
22.4 | 89.5 | GO:0015705 | iodide transport(GO:0015705) |
22.3 | 111.7 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
22.1 | 88.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
22.1 | 66.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
22.0 | 263.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
22.0 | 22.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
21.9 | 65.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
21.9 | 87.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
21.9 | 87.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
21.9 | 65.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
21.9 | 43.8 | GO:2000978 | regulation of forebrain neuron differentiation(GO:2000977) negative regulation of forebrain neuron differentiation(GO:2000978) |
21.8 | 65.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
21.8 | 109.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
21.8 | 43.5 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
21.7 | 65.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
21.7 | 21.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
21.7 | 43.4 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
21.6 | 64.8 | GO:0036394 | amylase secretion(GO:0036394) |
21.5 | 21.5 | GO:0061515 | myeloid cell development(GO:0061515) |
21.5 | 21.5 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
21.4 | 42.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
21.4 | 64.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
21.2 | 63.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
21.1 | 42.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
21.1 | 42.3 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
21.0 | 42.1 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
20.9 | 41.8 | GO:0051293 | establishment of spindle localization(GO:0051293) |
20.9 | 41.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
20.8 | 186.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
20.7 | 145.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
20.7 | 62.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
20.6 | 103.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
20.6 | 61.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
20.4 | 142.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
20.4 | 61.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
20.3 | 121.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
20.3 | 40.5 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
20.2 | 121.5 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
20.2 | 80.7 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
20.1 | 40.3 | GO:1901563 | response to camptothecin(GO:1901563) |
20.0 | 40.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
20.0 | 139.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
20.0 | 79.9 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
19.8 | 59.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
19.8 | 59.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
19.7 | 39.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
19.7 | 78.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
19.5 | 39.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
19.4 | 77.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
19.4 | 58.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
19.4 | 38.8 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
19.3 | 58.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
19.3 | 115.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
19.3 | 19.3 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
19.2 | 38.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
19.2 | 76.7 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
19.2 | 38.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
19.0 | 38.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
19.0 | 95.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
19.0 | 38.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
19.0 | 57.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
19.0 | 94.9 | GO:0016266 | O-glycan processing(GO:0016266) |
18.9 | 75.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
18.6 | 37.3 | GO:0070487 | monocyte aggregation(GO:0070487) |
18.5 | 55.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
18.5 | 18.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
18.4 | 184.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
18.4 | 128.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
18.4 | 55.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
18.3 | 73.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
18.2 | 36.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
18.2 | 54.5 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
18.1 | 36.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
18.1 | 108.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
18.1 | 72.4 | GO:0051697 | protein delipidation(GO:0051697) |
18.1 | 18.1 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
18.1 | 36.2 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
18.0 | 90.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
17.9 | 179.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
17.9 | 161.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
17.9 | 17.9 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
17.8 | 71.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
17.8 | 71.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
17.8 | 53.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
17.8 | 35.5 | GO:0072718 | response to cisplatin(GO:0072718) |
17.8 | 17.8 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
17.7 | 124.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
17.7 | 88.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
17.7 | 159.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
17.7 | 53.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
17.7 | 35.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
17.7 | 17.7 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
17.6 | 35.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
17.6 | 123.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
17.6 | 333.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
17.5 | 17.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
17.5 | 105.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
17.5 | 87.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
17.4 | 86.9 | GO:0036233 | glycine import(GO:0036233) |
17.3 | 69.3 | GO:0003383 | apical constriction(GO:0003383) |
17.2 | 17.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
17.2 | 51.6 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
17.2 | 86.0 | GO:0015816 | glycine transport(GO:0015816) |
17.1 | 85.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
17.1 | 34.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
17.1 | 188.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
17.1 | 34.2 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
17.1 | 51.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
17.0 | 51.0 | GO:0000087 | mitotic M phase(GO:0000087) |
16.9 | 33.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
16.9 | 33.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
16.9 | 67.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
16.9 | 50.7 | GO:0040031 | snRNA modification(GO:0040031) |
16.9 | 67.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
16.9 | 168.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
16.9 | 67.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
16.9 | 50.6 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
16.8 | 134.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
16.8 | 50.5 | GO:0034214 | protein hexamerization(GO:0034214) |
16.8 | 50.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
16.8 | 83.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
16.7 | 33.4 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
16.6 | 16.6 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
16.6 | 49.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
16.6 | 82.8 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
16.6 | 198.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
16.5 | 66.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
16.5 | 115.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
16.5 | 49.6 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
16.5 | 16.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) negative regulation of male germ cell proliferation(GO:2000255) |
16.5 | 115.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
16.4 | 115.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
16.4 | 49.3 | GO:0021564 | vagus nerve development(GO:0021564) |
16.4 | 49.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
16.4 | 81.8 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
16.3 | 48.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
16.3 | 81.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
16.2 | 113.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
16.2 | 32.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
16.2 | 48.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
16.1 | 80.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
16.1 | 64.5 | GO:0018101 | protein citrullination(GO:0018101) |
16.1 | 112.9 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
16.0 | 96.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
16.0 | 31.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
15.9 | 47.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
15.9 | 127.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
15.9 | 349.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
15.9 | 190.5 | GO:0032310 | prostaglandin secretion(GO:0032310) |
15.8 | 47.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
15.8 | 31.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
15.8 | 78.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
15.8 | 31.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
15.7 | 15.7 | GO:0030279 | negative regulation of ossification(GO:0030279) |
15.7 | 31.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
15.7 | 31.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
15.7 | 31.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
15.6 | 31.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
15.6 | 46.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
15.6 | 109.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
15.6 | 31.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
15.6 | 311.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
15.4 | 46.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
15.3 | 92.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
15.3 | 45.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
15.3 | 15.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
15.2 | 60.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
15.2 | 45.7 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
15.1 | 60.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
15.1 | 15.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
15.1 | 60.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
15.1 | 30.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
15.1 | 30.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
15.1 | 105.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
15.0 | 150.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
14.9 | 29.9 | GO:1902075 | cellular response to salt(GO:1902075) |
14.9 | 119.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
14.9 | 44.7 | GO:0019532 | oxalate transport(GO:0019532) |
14.9 | 44.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
14.8 | 59.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
14.8 | 14.8 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
14.7 | 147.2 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
14.7 | 102.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
14.7 | 44.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
14.7 | 308.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
14.7 | 29.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
14.6 | 117.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
14.6 | 219.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
14.6 | 160.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
14.6 | 174.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
14.5 | 421.9 | GO:0070527 | platelet aggregation(GO:0070527) |
14.5 | 14.5 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
14.5 | 101.7 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
14.5 | 29.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
14.5 | 43.5 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
14.5 | 14.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
14.5 | 43.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
14.5 | 14.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
14.4 | 14.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
14.4 | 43.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
14.4 | 86.3 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
14.4 | 14.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
14.4 | 129.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
14.4 | 43.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
14.3 | 14.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
14.2 | 42.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
14.2 | 28.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
14.2 | 170.5 | GO:0051601 | exocyst localization(GO:0051601) |
14.2 | 14.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
14.2 | 42.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
14.1 | 198.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
14.1 | 42.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
14.1 | 70.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
14.1 | 14.1 | GO:0034204 | lipid translocation(GO:0034204) |
14.1 | 70.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
14.0 | 14.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
14.0 | 98.2 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
14.0 | 14.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
14.0 | 98.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
14.0 | 28.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
14.0 | 28.0 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
14.0 | 14.0 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
14.0 | 223.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
14.0 | 41.9 | GO:0015886 | heme transport(GO:0015886) |
14.0 | 335.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
14.0 | 69.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
14.0 | 41.9 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
13.9 | 111.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
13.9 | 41.7 | GO:0032202 | telomere assembly(GO:0032202) |
13.9 | 83.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
13.9 | 41.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
13.8 | 540.0 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
13.8 | 41.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
13.7 | 13.7 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
13.7 | 137.4 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
13.7 | 54.8 | GO:0006007 | glucose catabolic process(GO:0006007) |
13.7 | 82.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
13.6 | 27.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
13.6 | 13.6 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
13.5 | 27.1 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
13.5 | 27.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
13.4 | 13.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
13.4 | 13.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
13.4 | 120.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
13.4 | 160.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
13.4 | 53.5 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
13.3 | 66.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
13.3 | 26.6 | GO:0070266 | necroptotic process(GO:0070266) |
13.3 | 291.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
13.3 | 66.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
13.2 | 39.6 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
13.2 | 39.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
13.2 | 26.3 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
13.1 | 13.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
13.1 | 26.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
13.1 | 13.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
13.0 | 156.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
13.0 | 26.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
13.0 | 39.1 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
13.0 | 234.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
13.0 | 26.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
13.0 | 51.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
13.0 | 51.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
13.0 | 77.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
13.0 | 129.5 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
12.9 | 12.9 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
12.9 | 25.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
12.8 | 141.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
12.8 | 64.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
12.8 | 25.6 | GO:0070459 | prolactin secretion(GO:0070459) |
12.8 | 38.4 | GO:0007525 | somatic muscle development(GO:0007525) |
12.8 | 140.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
12.7 | 140.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
12.7 | 229.0 | GO:0006491 | N-glycan processing(GO:0006491) |
12.7 | 12.7 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
12.7 | 12.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
12.7 | 25.3 | GO:0002215 | defense response to nematode(GO:0002215) |
12.6 | 37.9 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
12.6 | 101.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
12.6 | 25.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
12.6 | 37.8 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
12.6 | 37.8 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
12.6 | 62.9 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
12.5 | 37.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
12.5 | 37.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
12.5 | 12.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
12.5 | 24.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
12.5 | 137.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
12.5 | 99.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
12.5 | 149.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
12.5 | 74.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
12.4 | 37.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
12.4 | 49.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
12.4 | 62.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
12.4 | 24.8 | GO:0051409 | response to nitrosative stress(GO:0051409) |
12.4 | 24.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
12.4 | 49.6 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
12.4 | 12.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
12.4 | 24.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
12.3 | 148.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
12.3 | 61.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
12.3 | 12.3 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
12.3 | 135.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
12.3 | 37.0 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
12.3 | 110.8 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
12.3 | 24.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
12.2 | 36.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
12.2 | 122.3 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
12.2 | 280.4 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
12.2 | 73.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
12.2 | 36.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
12.2 | 12.2 | GO:0032439 | endosome localization(GO:0032439) |
12.2 | 60.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
12.1 | 12.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
12.1 | 12.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
12.1 | 48.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
12.0 | 12.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
12.0 | 35.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
12.0 | 35.9 | GO:0046112 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) nucleobase biosynthetic process(GO:0046112) |
12.0 | 35.9 | GO:0007296 | vitellogenesis(GO:0007296) |
11.9 | 191.0 | GO:0030488 | tRNA methylation(GO:0030488) |
11.9 | 23.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
11.9 | 23.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
11.9 | 83.1 | GO:0030575 | nuclear body organization(GO:0030575) |
11.8 | 23.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
11.8 | 35.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
11.8 | 23.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
11.8 | 59.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
11.8 | 129.6 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
11.8 | 105.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
11.8 | 141.0 | GO:0010842 | retina layer formation(GO:0010842) |
11.7 | 47.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
11.7 | 199.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
11.7 | 117.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
11.7 | 70.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
11.7 | 23.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
11.7 | 23.4 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
11.7 | 11.7 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
11.7 | 23.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
11.7 | 81.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
11.6 | 58.2 | GO:0018904 | ether metabolic process(GO:0018904) |
11.6 | 11.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
11.6 | 465.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
11.6 | 23.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
11.6 | 46.4 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
11.6 | 57.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
11.6 | 23.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
11.6 | 11.6 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
11.5 | 138.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
11.5 | 23.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
11.5 | 34.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
11.5 | 80.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
11.5 | 34.4 | GO:0015889 | cobalamin transport(GO:0015889) |
11.5 | 45.8 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
11.5 | 11.5 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
11.4 | 22.9 | GO:0019042 | viral latency(GO:0019042) |
11.4 | 22.8 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
11.4 | 11.4 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
11.3 | 11.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
11.3 | 33.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
11.2 | 56.2 | GO:0019695 | choline metabolic process(GO:0019695) |
11.2 | 56.2 | GO:0001842 | neural fold formation(GO:0001842) |
11.2 | 11.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
11.2 | 33.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
11.2 | 22.5 | GO:0032570 | response to progesterone(GO:0032570) |
11.2 | 44.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
11.2 | 22.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
11.2 | 22.4 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
11.2 | 33.6 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) |
11.2 | 11.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
11.2 | 44.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
11.2 | 67.0 | GO:0044351 | macropinocytosis(GO:0044351) |
11.1 | 33.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
11.1 | 55.5 | GO:0015807 | L-amino acid transport(GO:0015807) |
11.1 | 122.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
11.1 | 22.2 | GO:2000909 | sterol import(GO:0035376) regulation of cholesterol import(GO:0060620) cholesterol import(GO:0070508) regulation of sterol import(GO:2000909) |
11.1 | 33.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
11.1 | 132.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
11.1 | 11.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
11.0 | 154.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
11.0 | 11.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
11.0 | 11.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
10.9 | 87.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
10.9 | 21.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
10.9 | 76.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
10.9 | 21.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
10.9 | 54.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
10.8 | 65.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
10.8 | 10.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
10.8 | 356.9 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
10.8 | 108.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
10.8 | 43.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
10.8 | 75.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
10.8 | 140.4 | GO:0015858 | nucleoside transport(GO:0015858) |
10.8 | 54.0 | GO:0042023 | DNA endoreduplication(GO:0042023) |
10.8 | 10.8 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
10.8 | 21.6 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
10.8 | 21.5 | GO:0051099 | positive regulation of binding(GO:0051099) |
10.7 | 139.6 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
10.7 | 64.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
10.7 | 32.1 | GO:0044838 | cell quiescence(GO:0044838) |
10.6 | 31.9 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
10.6 | 31.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
10.6 | 63.6 | GO:0007097 | nuclear migration(GO:0007097) |
10.6 | 42.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
10.6 | 10.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
10.6 | 21.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
10.5 | 73.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
10.5 | 105.3 | GO:0001675 | acrosome assembly(GO:0001675) |
10.5 | 10.5 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
10.5 | 42.1 | GO:0090009 | primitive streak formation(GO:0090009) |
10.5 | 209.9 | GO:0006301 | postreplication repair(GO:0006301) |
10.5 | 21.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
10.5 | 41.9 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
10.4 | 41.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
10.4 | 83.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
10.4 | 31.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
10.4 | 72.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
10.4 | 20.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
10.4 | 93.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
10.4 | 51.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
10.4 | 31.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
10.4 | 31.1 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
10.3 | 496.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
10.3 | 31.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
10.3 | 31.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
10.3 | 10.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
10.3 | 390.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
10.3 | 10.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
10.3 | 51.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
10.3 | 10.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
10.3 | 61.5 | GO:0031167 | rRNA methylation(GO:0031167) |
10.3 | 82.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
10.2 | 10.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
10.2 | 20.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
10.2 | 20.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
10.2 | 30.6 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
10.2 | 30.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
10.2 | 10.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
10.2 | 122.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
10.2 | 81.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
10.1 | 40.6 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
10.1 | 10.1 | GO:0010447 | response to acidic pH(GO:0010447) |
10.1 | 91.0 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
10.1 | 50.5 | GO:0060056 | mammary gland involution(GO:0060056) |
10.1 | 30.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
10.1 | 50.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
10.1 | 20.2 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
10.1 | 10.1 | GO:0009124 | nucleoside monophosphate biosynthetic process(GO:0009124) |
10.1 | 30.2 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
10.0 | 60.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
10.0 | 10.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
10.0 | 19.9 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
10.0 | 49.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
10.0 | 39.8 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
9.9 | 29.8 | GO:0031577 | spindle checkpoint(GO:0031577) |
9.9 | 19.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
9.9 | 49.6 | GO:0009650 | UV protection(GO:0009650) |
9.9 | 238.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
9.9 | 39.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
9.9 | 19.8 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
9.9 | 49.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
9.8 | 9.8 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
9.8 | 19.7 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
9.8 | 58.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
9.8 | 49.0 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
9.8 | 29.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
9.8 | 19.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
9.7 | 29.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
9.7 | 29.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
9.7 | 9.7 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
9.7 | 96.6 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
9.7 | 38.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
9.6 | 86.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
9.6 | 9.6 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
9.6 | 38.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
9.6 | 9.6 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
9.6 | 9.6 | GO:0048254 | snoRNA localization(GO:0048254) |
9.6 | 38.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
9.6 | 86.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
9.6 | 57.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
9.6 | 47.9 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
9.6 | 38.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
9.6 | 9.6 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
9.5 | 19.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
9.5 | 66.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
9.5 | 19.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
9.5 | 37.9 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
9.5 | 9.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
9.4 | 75.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
9.4 | 9.4 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
9.4 | 28.3 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
9.4 | 226.0 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
9.4 | 9.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
9.4 | 9.4 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
9.4 | 9.4 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
9.4 | 9.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
9.4 | 337.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
9.3 | 56.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
9.3 | 177.4 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
9.3 | 37.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
9.3 | 28.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
9.3 | 9.3 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
9.3 | 18.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
9.3 | 37.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
9.3 | 18.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
9.3 | 27.9 | GO:0015825 | L-serine transport(GO:0015825) |
9.3 | 9.3 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
9.3 | 9.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
9.3 | 18.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
9.3 | 18.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
9.3 | 18.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
9.3 | 18.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
9.3 | 9.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
9.3 | 18.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
9.3 | 46.3 | GO:0051013 | microtubule severing(GO:0051013) |
9.2 | 46.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
9.2 | 55.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
9.2 | 18.5 | GO:0045055 | regulated exocytosis(GO:0045055) |
9.2 | 92.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
9.2 | 18.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
9.2 | 18.4 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
9.2 | 46.1 | GO:0046697 | decidualization(GO:0046697) |
9.2 | 36.8 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
9.2 | 18.4 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
9.2 | 9.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
9.2 | 36.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
9.2 | 18.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
9.2 | 54.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
9.1 | 200.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
9.1 | 27.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
9.1 | 36.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
9.1 | 36.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
9.1 | 27.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
9.1 | 54.5 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
9.1 | 9.1 | GO:0010948 | negative regulation of cell cycle process(GO:0010948) |
9.1 | 9.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
9.1 | 136.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
9.0 | 18.1 | GO:0046959 | habituation(GO:0046959) |
9.0 | 36.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
9.0 | 162.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
9.0 | 9.0 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
9.0 | 18.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
9.0 | 9.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
9.0 | 9.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
9.0 | 36.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
9.0 | 9.0 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
8.9 | 17.9 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
8.9 | 35.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
8.9 | 17.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
8.9 | 17.9 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
8.9 | 8.9 | GO:0035510 | DNA dealkylation(GO:0035510) demethylation(GO:0070988) |
8.9 | 62.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
8.9 | 133.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
8.9 | 8.9 | GO:0003156 | regulation of organ formation(GO:0003156) |
8.9 | 8.9 | GO:0015817 | histidine transport(GO:0015817) |
8.9 | 8.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
8.8 | 17.7 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
8.8 | 70.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
8.8 | 61.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
8.8 | 17.6 | GO:0009445 | putrescine metabolic process(GO:0009445) |
8.8 | 61.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
8.8 | 122.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
8.8 | 26.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
8.7 | 8.7 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
8.7 | 61.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
8.7 | 96.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
8.7 | 8.7 | GO:0002432 | granuloma formation(GO:0002432) |
8.7 | 17.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
8.7 | 8.7 | GO:0006536 | glutamate metabolic process(GO:0006536) |
8.7 | 26.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
8.7 | 86.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
8.7 | 43.3 | GO:0031643 | positive regulation of myelination(GO:0031643) |
8.6 | 17.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
8.6 | 8.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
8.6 | 60.5 | GO:0010039 | response to iron ion(GO:0010039) |
8.6 | 17.3 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
8.6 | 77.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
8.6 | 51.7 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
8.6 | 17.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
8.6 | 8.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
8.6 | 180.6 | GO:0032456 | endocytic recycling(GO:0032456) |
8.6 | 25.7 | GO:0030421 | defecation(GO:0030421) |
8.6 | 34.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
8.6 | 25.7 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
8.6 | 8.6 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
8.6 | 25.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
8.5 | 93.9 | GO:0009299 | mRNA transcription(GO:0009299) |
8.5 | 76.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
8.5 | 25.6 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
8.5 | 42.6 | GO:0000154 | rRNA modification(GO:0000154) |
8.5 | 8.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
8.5 | 17.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
8.5 | 76.4 | GO:0014044 | Schwann cell development(GO:0014044) |
8.5 | 33.9 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
8.5 | 67.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
8.5 | 42.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
8.5 | 50.7 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
8.4 | 16.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
8.4 | 25.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
8.4 | 50.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
8.4 | 33.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
8.4 | 16.8 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
8.4 | 25.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
8.4 | 16.8 | GO:0006971 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
8.4 | 8.4 | GO:0048478 | replication fork protection(GO:0048478) |
8.4 | 42.0 | GO:0015074 | DNA integration(GO:0015074) |
8.4 | 50.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
8.3 | 33.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
8.3 | 25.0 | GO:0060023 | soft palate development(GO:0060023) |
8.3 | 16.7 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
8.3 | 33.2 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
8.3 | 224.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
8.3 | 41.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
8.3 | 124.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
8.3 | 16.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
8.3 | 24.8 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
8.3 | 41.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
8.3 | 57.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
8.2 | 16.5 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
8.2 | 123.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
8.2 | 16.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
8.2 | 41.1 | GO:0046415 | urate metabolic process(GO:0046415) |
8.2 | 8.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
8.2 | 8.2 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
8.2 | 24.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
8.2 | 24.5 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
8.2 | 16.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
8.2 | 8.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
8.2 | 203.8 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
8.1 | 56.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
8.1 | 8.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
8.1 | 8.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
8.1 | 8.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
8.1 | 40.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
8.1 | 24.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
8.1 | 56.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
8.1 | 88.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
8.0 | 16.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
8.0 | 16.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
8.0 | 8.0 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
8.0 | 8.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
8.0 | 40.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
8.0 | 64.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
8.0 | 8.0 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
8.0 | 16.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
8.0 | 8.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
8.0 | 159.6 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
8.0 | 15.9 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
8.0 | 15.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
8.0 | 23.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
8.0 | 39.8 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
8.0 | 47.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
7.9 | 7.9 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
7.9 | 7.9 | GO:0006983 | ER overload response(GO:0006983) |
7.9 | 23.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
7.9 | 23.8 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
7.9 | 245.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
7.9 | 7.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
7.9 | 39.5 | GO:0015871 | choline transport(GO:0015871) |
7.9 | 23.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
7.9 | 47.4 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
7.9 | 39.4 | GO:0009249 | protein lipoylation(GO:0009249) |
7.8 | 23.5 | GO:0052547 | regulation of peptidase activity(GO:0052547) |
7.8 | 7.8 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
7.8 | 23.5 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
7.8 | 7.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
7.8 | 54.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
7.7 | 7.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
7.7 | 15.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
7.7 | 15.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
7.7 | 7.7 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
7.7 | 15.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
7.7 | 15.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
7.7 | 7.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
7.7 | 23.0 | GO:0090042 | tubulin deacetylation(GO:0090042) |
7.7 | 15.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
7.7 | 260.6 | GO:0006446 | regulation of translational initiation(GO:0006446) |
7.6 | 22.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
7.6 | 91.0 | GO:0030168 | platelet activation(GO:0030168) |
7.6 | 7.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
7.6 | 15.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
7.6 | 22.7 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) negative regulation of RIG-I signaling pathway(GO:0039536) |
7.6 | 15.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
7.6 | 7.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
7.5 | 150.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
7.5 | 15.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
7.5 | 37.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
7.5 | 15.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
7.5 | 97.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
7.5 | 22.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
7.5 | 15.0 | GO:0060613 | fat pad development(GO:0060613) |
7.5 | 52.4 | GO:1904851 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
7.5 | 7.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
7.5 | 22.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
7.5 | 52.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
7.5 | 7.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
7.5 | 37.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
7.5 | 44.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
7.5 | 52.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
7.4 | 14.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
7.4 | 59.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
7.4 | 7.4 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
7.4 | 52.0 | GO:0043248 | proteasome assembly(GO:0043248) |
7.4 | 44.5 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
7.4 | 7.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
7.4 | 14.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
7.4 | 7.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
7.4 | 44.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
7.4 | 14.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
7.4 | 7.4 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
7.3 | 7.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
7.3 | 14.7 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
7.3 | 7.3 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
7.3 | 14.7 | GO:0006304 | DNA modification(GO:0006304) |
7.3 | 73.3 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
7.3 | 14.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
7.3 | 29.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
7.3 | 21.9 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
7.3 | 21.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
7.3 | 21.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
7.3 | 29.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
7.3 | 72.7 | GO:0001659 | temperature homeostasis(GO:0001659) |
7.3 | 79.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
7.3 | 29.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
7.3 | 7.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
7.3 | 29.0 | GO:0016925 | protein sumoylation(GO:0016925) |
7.2 | 21.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
7.2 | 57.8 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
7.2 | 86.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
7.2 | 7.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
7.2 | 72.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
7.2 | 21.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
7.2 | 43.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
7.2 | 43.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
7.2 | 416.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
7.2 | 7.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
7.2 | 186.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
7.2 | 200.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
7.2 | 35.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
7.1 | 71.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
7.1 | 28.6 | GO:0071569 | protein ufmylation(GO:0071569) |
7.1 | 7.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
7.1 | 42.7 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
7.1 | 255.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
7.1 | 14.1 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
7.1 | 77.7 | GO:0060972 | left/right pattern formation(GO:0060972) |
7.1 | 49.4 | GO:0030261 | chromosome condensation(GO:0030261) |
7.1 | 21.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
7.0 | 21.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
7.0 | 49.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
7.0 | 63.3 | GO:0031648 | protein destabilization(GO:0031648) |
7.0 | 49.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
7.0 | 14.0 | GO:0046849 | bone remodeling(GO:0046849) |
7.0 | 35.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
7.0 | 21.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
7.0 | 7.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
7.0 | 146.6 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
7.0 | 27.9 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
7.0 | 62.6 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
6.9 | 34.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
6.9 | 6.9 | GO:0001556 | oocyte maturation(GO:0001556) |
6.9 | 13.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
6.9 | 13.8 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
6.9 | 82.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
6.9 | 6.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
6.9 | 27.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
6.9 | 171.8 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
6.9 | 48.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
6.9 | 6.9 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
6.8 | 6.8 | GO:0030818 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
6.8 | 109.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
6.8 | 102.6 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
6.8 | 34.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
6.8 | 20.5 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
6.8 | 20.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
6.8 | 34.0 | GO:0006477 | protein sulfation(GO:0006477) |
6.8 | 34.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
6.8 | 20.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
6.8 | 176.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
6.8 | 27.1 | GO:0006116 | NADH oxidation(GO:0006116) |
6.8 | 47.4 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
6.8 | 13.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
6.8 | 6.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
6.8 | 6.8 | GO:0016574 | histone ubiquitination(GO:0016574) |
6.7 | 20.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
6.7 | 256.1 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
6.7 | 13.5 | GO:1903578 | regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
6.7 | 6.7 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
6.7 | 26.9 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
6.7 | 20.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
6.7 | 20.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
6.7 | 13.4 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
6.7 | 26.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
6.7 | 6.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
6.7 | 26.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
6.7 | 20.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
6.7 | 40.1 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
6.7 | 6.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
6.7 | 60.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
6.7 | 20.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
6.7 | 33.3 | GO:0030033 | microvillus assembly(GO:0030033) |
6.6 | 13.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
6.6 | 46.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
6.6 | 13.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
6.6 | 13.2 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
6.6 | 52.5 | GO:0051450 | myoblast proliferation(GO:0051450) |
6.6 | 13.1 | GO:0097484 | dendrite extension(GO:0097484) |
6.5 | 26.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
6.5 | 71.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
6.5 | 430.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
6.5 | 39.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
6.5 | 19.5 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
6.5 | 52.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
6.5 | 19.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
6.5 | 6.5 | GO:0018377 | protein myristoylation(GO:0018377) |
6.5 | 25.8 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
6.5 | 38.7 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
6.4 | 19.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
6.4 | 25.8 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
6.4 | 6.4 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
6.4 | 32.1 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
6.4 | 6.4 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
6.4 | 102.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
6.4 | 25.6 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
6.4 | 12.8 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
6.4 | 6.4 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
6.4 | 12.8 | GO:0015884 | folic acid transport(GO:0015884) |
6.4 | 25.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
6.4 | 19.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
6.4 | 25.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
6.4 | 31.9 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
6.4 | 57.4 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
6.4 | 6.4 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
6.4 | 19.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
6.4 | 6.4 | GO:0043038 | amino acid activation(GO:0043038) |
6.4 | 38.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
6.3 | 6.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
6.3 | 6.3 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
6.3 | 25.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
6.3 | 12.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
6.3 | 31.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
6.3 | 44.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
6.3 | 176.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
6.3 | 12.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
6.3 | 12.6 | GO:0044778 | meiotic cell cycle checkpoint(GO:0033313) meiotic DNA integrity checkpoint(GO:0044778) |
6.3 | 31.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
6.3 | 18.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
6.3 | 6.3 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
6.3 | 6.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
6.3 | 50.3 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
6.3 | 12.6 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) chromosome movement towards spindle pole(GO:0051305) |
6.3 | 12.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
6.2 | 99.9 | GO:0017144 | drug metabolic process(GO:0017144) |
6.2 | 12.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
6.2 | 49.8 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
6.2 | 49.5 | GO:0051289 | protein homotetramerization(GO:0051289) |
6.2 | 24.7 | GO:0010165 | response to X-ray(GO:0010165) |
6.2 | 74.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
6.2 | 6.2 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
6.2 | 12.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
6.2 | 104.9 | GO:0051168 | nuclear export(GO:0051168) |
6.2 | 67.8 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
6.2 | 24.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
6.1 | 12.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
6.1 | 12.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
6.1 | 6.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
6.1 | 12.2 | GO:0048771 | tissue remodeling(GO:0048771) |
6.1 | 18.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
6.1 | 18.3 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
6.1 | 6.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
6.1 | 6.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
6.1 | 12.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
6.1 | 12.1 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
6.1 | 6.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
6.1 | 24.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
6.1 | 12.1 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
6.1 | 6.1 | GO:0009451 | RNA modification(GO:0009451) |
6.0 | 127.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
6.0 | 30.2 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
6.0 | 350.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
6.0 | 6.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
6.0 | 6.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
6.0 | 36.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
6.0 | 18.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
6.0 | 522.9 | GO:0006310 | DNA recombination(GO:0006310) |
6.0 | 120.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
6.0 | 6.0 | GO:0006534 | cysteine metabolic process(GO:0006534) homocysteine metabolic process(GO:0050667) |
6.0 | 12.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
6.0 | 29.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
6.0 | 18.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
6.0 | 17.9 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
6.0 | 6.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
6.0 | 6.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
6.0 | 11.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
6.0 | 6.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
6.0 | 11.9 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
5.9 | 5.9 | GO:0007599 | hemostasis(GO:0007599) |
5.9 | 11.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
5.9 | 17.8 | GO:0071407 | cellular response to organic cyclic compound(GO:0071407) |
5.9 | 47.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
5.9 | 5.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
5.9 | 47.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
5.9 | 11.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
5.9 | 11.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
5.9 | 5.9 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
5.9 | 17.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
5.8 | 5.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
5.8 | 58.2 | GO:0002021 | response to dietary excess(GO:0002021) |
5.8 | 5.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
5.8 | 11.6 | GO:0055088 | lipid homeostasis(GO:0055088) |
5.8 | 17.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
5.8 | 11.5 | GO:0016556 | mRNA modification(GO:0016556) |
5.8 | 5.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
5.8 | 11.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
5.7 | 5.7 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
5.7 | 22.9 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
5.7 | 5.7 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
5.7 | 79.8 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
5.7 | 56.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
5.7 | 11.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
5.7 | 11.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
5.7 | 158.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
5.7 | 11.3 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
5.6 | 11.3 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
5.6 | 16.9 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
5.6 | 11.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
5.6 | 124.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
5.6 | 16.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
5.6 | 95.8 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
5.6 | 5.6 | GO:0007343 | egg activation(GO:0007343) |
5.6 | 28.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
5.6 | 106.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
5.6 | 55.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
5.6 | 66.9 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
5.6 | 16.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
5.6 | 16.7 | GO:0007000 | nucleolus organization(GO:0007000) |
5.6 | 105.6 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
5.6 | 11.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
5.6 | 33.3 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
5.5 | 44.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
5.5 | 22.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
5.5 | 5.5 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
5.5 | 5.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
5.5 | 5.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
5.5 | 11.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
5.5 | 11.0 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
5.5 | 16.5 | GO:0060405 | regulation of penile erection(GO:0060405) |
5.5 | 33.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
5.5 | 5.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
5.5 | 16.4 | GO:0033273 | response to vitamin(GO:0033273) |
5.5 | 27.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
5.5 | 27.4 | GO:0061462 | protein localization to lysosome(GO:0061462) |
5.4 | 27.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
5.4 | 114.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
5.4 | 16.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
5.4 | 21.7 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
5.4 | 10.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
5.4 | 5.4 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
5.4 | 5.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
5.4 | 16.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
5.4 | 5.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
5.4 | 26.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
5.4 | 102.2 | GO:0051028 | mRNA transport(GO:0051028) |
5.4 | 16.1 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
5.4 | 21.5 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
5.4 | 42.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
5.4 | 53.6 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
5.3 | 42.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
5.3 | 16.0 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
5.3 | 90.3 | GO:0030042 | actin filament depolymerization(GO:0030042) |
5.3 | 15.9 | GO:0061450 | trophoblast cell migration(GO:0061450) |
5.3 | 5.3 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
5.3 | 105.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
5.3 | 15.9 | GO:0002159 | desmosome assembly(GO:0002159) |
5.3 | 5.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
5.3 | 15.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
5.3 | 10.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
5.3 | 10.6 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
5.3 | 5.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
5.2 | 26.2 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
5.2 | 10.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
5.2 | 162.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
5.2 | 57.6 | GO:0016180 | snRNA processing(GO:0016180) |
5.2 | 5.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
5.2 | 31.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
5.2 | 125.4 | GO:0045576 | mast cell activation(GO:0045576) |
5.2 | 10.4 | GO:0060068 | vagina development(GO:0060068) |
5.2 | 26.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
5.2 | 15.6 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
5.2 | 5.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
5.2 | 20.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
5.2 | 20.8 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
5.2 | 31.1 | GO:0015809 | arginine transport(GO:0015809) |
5.2 | 31.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
5.2 | 72.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
5.2 | 5.2 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
5.2 | 5.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
5.2 | 77.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
5.2 | 15.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
5.2 | 20.7 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
5.2 | 10.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
5.2 | 5.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
5.2 | 5.2 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
5.2 | 5.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
5.1 | 113.1 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
5.1 | 5.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
5.1 | 25.7 | GO:0034063 | stress granule assembly(GO:0034063) |
5.1 | 10.3 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
5.1 | 20.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
5.1 | 10.3 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
5.1 | 41.0 | GO:0019915 | lipid storage(GO:0019915) |
5.1 | 61.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
5.1 | 5.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
5.1 | 5.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
5.1 | 5.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
5.1 | 40.6 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
5.1 | 10.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
5.1 | 10.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
5.1 | 15.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
5.0 | 5.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
5.0 | 75.4 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
5.0 | 5.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
5.0 | 15.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
5.0 | 40.2 | GO:0044804 | nucleophagy(GO:0044804) |
5.0 | 5.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) positive regulation of catecholamine secretion(GO:0033605) |
5.0 | 10.0 | GO:0051029 | rRNA transport(GO:0051029) |
5.0 | 20.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
5.0 | 5.0 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
5.0 | 24.8 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
5.0 | 5.0 | GO:0019674 | NAD metabolic process(GO:0019674) |
5.0 | 59.5 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
5.0 | 29.7 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
4.9 | 19.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
4.9 | 39.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
4.9 | 9.9 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
4.9 | 14.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
4.9 | 19.8 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
4.9 | 19.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
4.9 | 4.9 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
4.9 | 4.9 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
4.9 | 9.8 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
4.9 | 49.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
4.9 | 9.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
4.9 | 29.4 | GO:0032060 | bleb assembly(GO:0032060) |
4.9 | 245.0 | GO:0051607 | defense response to virus(GO:0051607) |
4.9 | 9.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
4.9 | 4.9 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
4.9 | 53.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
4.9 | 4.9 | GO:0034502 | protein localization to chromosome(GO:0034502) |
4.9 | 999.2 | GO:0008380 | RNA splicing(GO:0008380) |
4.9 | 4.9 | GO:0090110 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
4.9 | 209.4 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
4.9 | 403.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
4.8 | 9.7 | GO:0033762 | response to glucagon(GO:0033762) |
4.8 | 67.7 | GO:0009206 | ATP biosynthetic process(GO:0006754) purine nucleoside triphosphate biosynthetic process(GO:0009145) ribonucleoside triphosphate biosynthetic process(GO:0009201) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
4.8 | 9.7 | GO:0031639 | plasminogen activation(GO:0031639) |
4.8 | 14.5 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
4.8 | 19.3 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
4.8 | 120.6 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
4.8 | 19.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
4.8 | 4.8 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
4.8 | 14.5 | GO:0070265 | necrotic cell death(GO:0070265) |
4.8 | 9.6 | GO:0038066 | p38MAPK cascade(GO:0038066) |
4.8 | 4.8 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
4.8 | 4.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
4.8 | 4.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
4.8 | 9.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
4.8 | 14.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
4.8 | 52.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
4.8 | 19.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
4.8 | 9.6 | GO:0030242 | pexophagy(GO:0030242) |
4.8 | 33.4 | GO:0008209 | androgen metabolic process(GO:0008209) |
4.8 | 47.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
4.8 | 9.5 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
4.8 | 19.0 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
4.7 | 4.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
4.7 | 147.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
4.7 | 33.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
4.7 | 23.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
4.7 | 9.4 | GO:0019079 | viral genome replication(GO:0019079) |
4.7 | 37.7 | GO:0045116 | protein neddylation(GO:0045116) |
4.7 | 33.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
4.7 | 33.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
4.7 | 14.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
4.7 | 4.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
4.7 | 9.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
4.7 | 98.6 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
4.7 | 51.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
4.7 | 9.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
4.7 | 126.5 | GO:0051297 | centrosome organization(GO:0051297) |
4.7 | 18.7 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
4.7 | 46.8 | GO:0072676 | lymphocyte migration(GO:0072676) |
4.7 | 18.7 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
4.7 | 4.7 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
4.7 | 4.7 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
4.6 | 152.9 | GO:0010942 | positive regulation of cell death(GO:0010942) |
4.6 | 9.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
4.6 | 9.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
4.6 | 4.6 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
4.6 | 18.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
4.6 | 9.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
4.6 | 41.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
4.6 | 9.1 | GO:0097264 | self proteolysis(GO:0097264) |
4.6 | 13.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
4.5 | 4.5 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
4.5 | 9.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
4.5 | 4.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
4.5 | 9.1 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
4.5 | 18.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
4.5 | 9.1 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
4.5 | 9.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
4.5 | 9.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
4.5 | 85.6 | GO:0035966 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
4.5 | 18.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
4.5 | 4.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
4.5 | 40.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
4.5 | 13.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
4.5 | 13.4 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
4.4 | 4.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
4.4 | 8.9 | GO:0007144 | female meiosis I(GO:0007144) |
4.4 | 8.9 | GO:0006903 | vesicle targeting(GO:0006903) |
4.4 | 26.6 | GO:0030539 | male genitalia development(GO:0030539) |
4.4 | 13.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
4.4 | 22.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
4.4 | 66.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
4.4 | 8.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
4.4 | 4.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
4.4 | 4.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
4.4 | 4.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
4.4 | 30.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
4.4 | 30.7 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
4.4 | 192.3 | GO:0008033 | tRNA processing(GO:0008033) |
4.4 | 8.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
4.3 | 8.7 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
4.3 | 21.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
4.3 | 8.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
4.3 | 8.7 | GO:0016322 | neuron remodeling(GO:0016322) |
4.3 | 21.6 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
4.3 | 43.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
4.3 | 266.4 | GO:0016072 | rRNA metabolic process(GO:0016072) |
4.3 | 4.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
4.3 | 4.3 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
4.3 | 111.0 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
4.3 | 29.8 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
4.2 | 25.5 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
4.2 | 8.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
4.2 | 29.7 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
4.2 | 8.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
4.2 | 25.4 | GO:0010390 | histone monoubiquitination(GO:0010390) |
4.2 | 21.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
4.2 | 21.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
4.2 | 4.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
4.2 | 12.6 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
4.2 | 58.7 | GO:0007569 | cell aging(GO:0007569) |
4.2 | 50.2 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
4.2 | 16.6 | GO:0098840 | protein transport along microtubule(GO:0098840) |
4.2 | 419.9 | GO:0032259 | methylation(GO:0032259) |
4.2 | 8.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
4.2 | 74.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
4.1 | 16.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
4.1 | 4.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
4.1 | 4.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
4.1 | 16.6 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
4.1 | 4.1 | GO:0050777 | negative regulation of immune response(GO:0050777) |
4.1 | 24.8 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
4.1 | 16.5 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
4.1 | 20.5 | GO:0048535 | lymph node development(GO:0048535) |
4.1 | 4.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
4.1 | 8.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
4.1 | 8.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
4.1 | 4.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
4.1 | 24.6 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
4.1 | 4.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
4.1 | 4.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
4.1 | 4.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
4.1 | 8.1 | GO:0070305 | response to cGMP(GO:0070305) |
4.1 | 85.2 | GO:0009988 | cell-cell recognition(GO:0009988) |
4.1 | 16.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
4.0 | 16.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
4.0 | 4.0 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
4.0 | 8.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
4.0 | 84.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
4.0 | 32.2 | GO:0042991 | transcription factor import into nucleus(GO:0042991) |
4.0 | 60.3 | GO:0016575 | histone deacetylation(GO:0016575) |
4.0 | 12.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
4.0 | 16.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
4.0 | 4.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
4.0 | 15.9 | GO:0043276 | anoikis(GO:0043276) |
4.0 | 43.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
4.0 | 4.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
3.9 | 3.9 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
3.9 | 7.9 | GO:0046909 | intermembrane transport(GO:0046909) |
3.9 | 7.8 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
3.9 | 78.3 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
3.9 | 7.8 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
3.9 | 23.4 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
3.9 | 7.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
3.9 | 27.2 | GO:0000338 | protein deneddylation(GO:0000338) |
3.9 | 7.8 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
3.9 | 7.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
3.9 | 27.1 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
3.9 | 30.9 | GO:0043297 | apical junction assembly(GO:0043297) |
3.9 | 81.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
3.9 | 15.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
3.8 | 3.8 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
3.8 | 11.5 | GO:0006071 | glycerol metabolic process(GO:0006071) |
3.8 | 69.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
3.8 | 49.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
3.8 | 38.3 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
3.8 | 7.6 | GO:0042092 | type 2 immune response(GO:0042092) |
3.8 | 7.6 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
3.8 | 22.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
3.8 | 11.4 | GO:0060618 | nipple development(GO:0060618) |
3.8 | 15.2 | GO:0001553 | luteinization(GO:0001553) |
3.8 | 41.9 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
3.8 | 15.2 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
3.8 | 3.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
3.8 | 15.2 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
3.8 | 3.8 | GO:0021764 | amygdala development(GO:0021764) |
3.8 | 71.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
3.8 | 165.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
3.8 | 7.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
3.7 | 3.7 | GO:0014002 | astrocyte development(GO:0014002) |
3.7 | 11.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
3.7 | 7.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
3.7 | 22.4 | GO:0014904 | myotube cell development(GO:0014904) |
3.7 | 52.1 | GO:0006821 | chloride transport(GO:0006821) |
3.7 | 3.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
3.7 | 36.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
3.7 | 11.0 | GO:0097320 | membrane tubulation(GO:0097320) |
3.6 | 7.3 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
3.6 | 3.6 | GO:0070417 | cellular response to cold(GO:0070417) |
3.6 | 10.9 | GO:0030325 | adrenal gland development(GO:0030325) |
3.6 | 21.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
3.6 | 14.5 | GO:0007492 | endoderm development(GO:0007492) |
3.6 | 7.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
3.6 | 3.6 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
3.6 | 195.2 | GO:0006396 | RNA processing(GO:0006396) |
3.6 | 3.6 | GO:0009584 | detection of visible light(GO:0009584) |
3.6 | 39.7 | GO:0045727 | positive regulation of translation(GO:0045727) |
3.6 | 39.5 | GO:0034505 | tooth mineralization(GO:0034505) |
3.6 | 7.2 | GO:0048599 | oocyte development(GO:0048599) |
3.6 | 3.6 | GO:0060416 | response to growth hormone(GO:0060416) |
3.6 | 7.2 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
3.6 | 3.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
3.6 | 14.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
3.5 | 28.3 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
3.5 | 10.6 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
3.5 | 7.1 | GO:0071773 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
3.5 | 10.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
3.5 | 3.5 | GO:0015698 | inorganic anion transport(GO:0015698) |
3.5 | 28.2 | GO:0048144 | fibroblast proliferation(GO:0048144) |
3.5 | 10.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
3.5 | 28.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
3.5 | 14.0 | GO:0045453 | bone resorption(GO:0045453) |
3.5 | 62.9 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
3.5 | 7.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
3.5 | 10.4 | GO:0010470 | regulation of gastrulation(GO:0010470) |
3.5 | 27.8 | GO:0001706 | endoderm formation(GO:0001706) |
3.5 | 27.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
3.5 | 3.5 | GO:0046070 | dGTP metabolic process(GO:0046070) |
3.5 | 162.3 | GO:0045444 | fat cell differentiation(GO:0045444) |
3.4 | 3.4 | GO:0051591 | response to cAMP(GO:0051591) |
3.4 | 44.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
3.4 | 3.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
3.4 | 82.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
3.4 | 13.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
3.4 | 13.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
3.4 | 27.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
3.4 | 10.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
3.4 | 13.6 | GO:1901660 | calcium ion export(GO:1901660) |
3.4 | 6.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
3.4 | 16.9 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
3.4 | 30.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
3.4 | 134.7 | GO:0006281 | DNA repair(GO:0006281) |
3.4 | 10.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
3.4 | 6.7 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
3.4 | 3.4 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
3.3 | 16.7 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
3.3 | 3.3 | GO:0030431 | sleep(GO:0030431) |
3.3 | 16.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
3.3 | 23.4 | GO:1990403 | embryonic brain development(GO:1990403) |
3.3 | 16.7 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
3.3 | 3.3 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
3.3 | 3.3 | GO:0070384 | Harderian gland development(GO:0070384) |
3.3 | 3.3 | GO:0042312 | regulation of vasodilation(GO:0042312) |
3.3 | 72.7 | GO:0009408 | response to heat(GO:0009408) |
3.3 | 78.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
3.3 | 36.1 | GO:0009411 | response to UV(GO:0009411) |
3.3 | 9.8 | GO:1903232 | melanosome assembly(GO:1903232) |
3.3 | 3.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
3.3 | 6.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
3.3 | 3.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
3.3 | 29.3 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
3.3 | 19.5 | GO:0070670 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
3.2 | 6.5 | GO:0048255 | mRNA stabilization(GO:0048255) |
3.2 | 355.9 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
3.2 | 54.9 | GO:0009060 | aerobic respiration(GO:0009060) |
3.2 | 9.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
3.2 | 12.9 | GO:0007032 | endosome organization(GO:0007032) |
3.2 | 35.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
3.2 | 38.6 | GO:0043627 | response to estrogen(GO:0043627) |
3.2 | 3.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
3.2 | 3.2 | GO:0050755 | chemokine metabolic process(GO:0050755) |
3.2 | 54.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
3.2 | 9.5 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
3.2 | 6.4 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
3.2 | 9.5 | GO:0060005 | vestibular reflex(GO:0060005) |
3.2 | 3.2 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
3.1 | 9.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
3.1 | 6.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
3.1 | 6.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
3.1 | 28.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
3.1 | 9.3 | GO:0097435 | fibril organization(GO:0097435) |
3.1 | 34.2 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
3.1 | 6.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
3.1 | 3.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
3.1 | 6.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
3.1 | 48.9 | GO:0034728 | nucleosome organization(GO:0034728) |
3.1 | 3.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
3.0 | 3.0 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
3.0 | 12.1 | GO:0015893 | drug transport(GO:0015893) |
3.0 | 9.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
3.0 | 9.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
3.0 | 12.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
3.0 | 48.2 | GO:0007030 | Golgi organization(GO:0007030) |
3.0 | 21.1 | GO:0016926 | protein desumoylation(GO:0016926) |
3.0 | 3.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
3.0 | 12.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
3.0 | 6.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
3.0 | 6.0 | GO:0006399 | tRNA metabolic process(GO:0006399) |
3.0 | 116.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
3.0 | 3.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
3.0 | 11.9 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
3.0 | 14.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
3.0 | 3.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
3.0 | 3.0 | GO:0043383 | negative T cell selection(GO:0043383) |
2.9 | 2.9 | GO:0032098 | regulation of appetite(GO:0032098) |
2.9 | 2.9 | GO:0097286 | iron ion import(GO:0097286) |
2.9 | 79.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
2.9 | 14.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
2.9 | 104.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
2.9 | 180.4 | GO:0042060 | wound healing(GO:0042060) |
2.9 | 37.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
2.9 | 8.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
2.9 | 210.4 | GO:0006470 | protein dephosphorylation(GO:0006470) |
2.9 | 5.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
2.9 | 2.9 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
2.9 | 8.6 | GO:0051642 | centrosome localization(GO:0051642) |
2.8 | 2.8 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
2.8 | 14.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
2.8 | 2.8 | GO:0042637 | catagen(GO:0042637) |
2.8 | 14.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
2.8 | 14.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
2.8 | 11.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
2.8 | 2.8 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
2.8 | 11.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
2.8 | 8.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
2.8 | 106.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
2.8 | 2.8 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
2.8 | 8.4 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
2.8 | 30.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
2.8 | 8.3 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
2.8 | 5.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
2.8 | 5.5 | GO:0006414 | translational elongation(GO:0006414) |
2.8 | 2.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
2.8 | 5.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
2.8 | 2.8 | GO:0006591 | ornithine metabolic process(GO:0006591) |
2.8 | 5.5 | GO:0003170 | heart valve development(GO:0003170) |
2.7 | 129.0 | GO:0006457 | protein folding(GO:0006457) |
2.7 | 2.7 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
2.7 | 2.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
2.7 | 81.0 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
2.7 | 32.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.7 | 5.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
2.7 | 2.7 | GO:0015695 | organic cation transport(GO:0015695) |
2.7 | 79.7 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
2.6 | 60.9 | GO:0007519 | skeletal muscle tissue development(GO:0007519) skeletal muscle organ development(GO:0060538) |
2.6 | 329.4 | GO:0006412 | translation(GO:0006412) |
2.6 | 2.6 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
2.6 | 5.2 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
2.6 | 15.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
2.6 | 2.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
2.6 | 13.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
2.6 | 5.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
2.6 | 13.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
2.6 | 2.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.6 | 5.2 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
2.6 | 7.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
2.6 | 20.7 | GO:0008272 | sulfate transport(GO:0008272) |
2.6 | 69.7 | GO:0006006 | glucose metabolic process(GO:0006006) |
2.6 | 25.8 | GO:0060325 | face morphogenesis(GO:0060325) |
2.6 | 10.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
2.6 | 5.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
2.6 | 112.4 | GO:0070647 | protein modification by small protein conjugation or removal(GO:0070647) |
2.5 | 5.1 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
2.5 | 7.6 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
2.5 | 35.5 | GO:0006953 | acute-phase response(GO:0006953) |
2.5 | 32.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
2.5 | 7.5 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
2.5 | 5.0 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
2.5 | 2.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
2.5 | 52.4 | GO:0042493 | response to drug(GO:0042493) |
2.5 | 2.5 | GO:1903998 | regulation of eating behavior(GO:1903998) |
2.5 | 2.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
2.5 | 2.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
2.5 | 4.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
2.5 | 2.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
2.5 | 2.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
2.5 | 4.9 | GO:0071467 | cellular response to pH(GO:0071467) |
2.5 | 2.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
2.4 | 4.9 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
2.4 | 2.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
2.4 | 2.4 | GO:0045778 | positive regulation of ossification(GO:0045778) |
2.4 | 12.2 | GO:0006825 | copper ion transport(GO:0006825) |
2.4 | 2.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
2.4 | 4.8 | GO:0042891 | antibiotic transport(GO:0042891) |
2.4 | 4.8 | GO:0051657 | maintenance of organelle location(GO:0051657) |
2.4 | 2.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
2.4 | 7.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.4 | 4.8 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
2.4 | 4.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
2.4 | 9.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
2.4 | 576.6 | GO:0055114 | oxidation-reduction process(GO:0055114) |
2.4 | 2.4 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) |
2.4 | 9.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
2.4 | 14.1 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
2.4 | 11.8 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
2.3 | 2.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.3 | 25.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
2.3 | 9.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
2.3 | 4.7 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
2.3 | 9.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
2.3 | 20.7 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
2.3 | 16.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
2.3 | 18.4 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
2.3 | 9.2 | GO:0001967 | suckling behavior(GO:0001967) |
2.3 | 11.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
2.3 | 2.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
2.3 | 4.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.3 | 4.5 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
2.3 | 4.5 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
2.3 | 4.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
2.3 | 2.3 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
2.3 | 2.3 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway(GO:2001242) |
2.2 | 2.2 | GO:0046958 | nonassociative learning(GO:0046958) |
2.2 | 2.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
2.2 | 2.2 | GO:0007412 | axon target recognition(GO:0007412) |
2.2 | 51.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
2.2 | 2.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
2.2 | 11.1 | GO:0007127 | meiosis I(GO:0007127) |
2.2 | 2.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
2.2 | 2.2 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
2.2 | 6.7 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
2.2 | 2.2 | GO:0070633 | transepithelial transport(GO:0070633) |
2.2 | 2.2 | GO:0048525 | negative regulation of viral process(GO:0048525) |
2.2 | 15.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
2.2 | 2.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
2.2 | 2.2 | GO:0050798 | activated T cell proliferation(GO:0050798) |
2.2 | 17.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
2.2 | 8.6 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
2.1 | 6.4 | GO:0032868 | response to insulin(GO:0032868) |
2.1 | 6.4 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
2.1 | 8.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
2.1 | 6.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
2.1 | 4.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
2.1 | 2.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
2.1 | 4.2 | GO:0006265 | DNA topological change(GO:0006265) |
2.1 | 2.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.1 | 4.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
2.1 | 37.4 | GO:0007059 | chromosome segregation(GO:0007059) |
2.1 | 2.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.1 | 4.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
2.1 | 180.7 | GO:0051346 | negative regulation of hydrolase activity(GO:0051346) |
2.1 | 326.5 | GO:0048232 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
2.1 | 112.9 | GO:0060271 | cilium morphogenesis(GO:0060271) |
2.1 | 18.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.0 | 2.0 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
2.0 | 18.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
2.0 | 10.1 | GO:0009615 | response to virus(GO:0009615) |
2.0 | 2.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
2.0 | 6.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
2.0 | 12.1 | GO:0042278 | purine nucleoside metabolic process(GO:0042278) |
2.0 | 4.0 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
2.0 | 2.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
2.0 | 2.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
2.0 | 9.9 | GO:0006884 | cell volume homeostasis(GO:0006884) |
2.0 | 2.0 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
2.0 | 5.9 | GO:0006465 | signal peptide processing(GO:0006465) |
2.0 | 13.8 | GO:0007631 | feeding behavior(GO:0007631) |
2.0 | 15.7 | GO:0014850 | response to muscle activity(GO:0014850) |
2.0 | 3.9 | GO:0050892 | intestinal absorption(GO:0050892) |
2.0 | 3.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.9 | 3.9 | GO:0097480 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
1.9 | 19.5 | GO:0007034 | vacuolar transport(GO:0007034) |
1.9 | 1.9 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
1.9 | 1.9 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.9 | 3.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
1.9 | 3.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.9 | 11.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
1.9 | 3.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.9 | 1.9 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
1.9 | 1.9 | GO:0045924 | regulation of female receptivity(GO:0045924) |
1.8 | 1.8 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
1.8 | 49.5 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
1.8 | 1.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.8 | 1.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.8 | 1.8 | GO:0002931 | response to ischemia(GO:0002931) |
1.8 | 1.8 | GO:0090313 | regulation of protein targeting to membrane(GO:0090313) |
1.8 | 1.8 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
1.8 | 5.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
1.8 | 3.5 | GO:0044843 | cell cycle G1/S phase transition(GO:0044843) |
1.8 | 5.3 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
1.7 | 73.2 | GO:0016042 | lipid catabolic process(GO:0016042) |
1.7 | 5.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
1.7 | 1.7 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
1.7 | 43.0 | GO:0006906 | vesicle fusion(GO:0006906) |
1.7 | 6.8 | GO:0031638 | zymogen activation(GO:0031638) |
1.7 | 1.7 | GO:0045933 | positive regulation of muscle contraction(GO:0045933) |
1.7 | 80.7 | GO:0006816 | calcium ion transport(GO:0006816) |
1.7 | 31.9 | GO:0031424 | keratinization(GO:0031424) |
1.7 | 1.7 | GO:0001895 | retina homeostasis(GO:0001895) |
1.7 | 1.7 | GO:0032370 | positive regulation of lipid transport(GO:0032370) |
1.7 | 15.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
1.7 | 1.7 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
1.7 | 3.3 | GO:0060711 | labyrinthine layer development(GO:0060711) |
1.6 | 1.6 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
1.6 | 4.9 | GO:0050701 | interleukin-1 secretion(GO:0050701) interleukin-1 beta secretion(GO:0050702) |
1.6 | 6.5 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
1.6 | 1.6 | GO:0035878 | nail development(GO:0035878) |
1.6 | 1.6 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
1.6 | 21.1 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
1.6 | 8.1 | GO:0042159 | protein depalmitoylation(GO:0002084) lipoprotein catabolic process(GO:0042159) macromolecule depalmitoylation(GO:0098734) |
1.6 | 1.6 | GO:0046324 | regulation of glucose import(GO:0046324) |
1.6 | 1.6 | GO:2000021 | regulation of ion homeostasis(GO:2000021) |
1.6 | 1.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.6 | 3.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
1.6 | 3.2 | GO:0051014 | actin filament severing(GO:0051014) |
1.6 | 7.9 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
1.6 | 4.7 | GO:0050832 | defense response to fungus(GO:0050832) |
1.6 | 1.6 | GO:0048102 | autophagic cell death(GO:0048102) |
1.6 | 73.6 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
1.5 | 12.2 | GO:0016050 | vesicle organization(GO:0016050) |
1.5 | 21.3 | GO:0048545 | response to steroid hormone(GO:0048545) |
1.5 | 14.9 | GO:0019835 | cytolysis(GO:0019835) |
1.5 | 1.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.5 | 1.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.5 | 7.3 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
1.5 | 20.4 | GO:0006873 | cellular ion homeostasis(GO:0006873) |
1.5 | 4.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.4 | 1.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.4 | 5.8 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
1.4 | 35.9 | GO:0072507 | divalent inorganic cation homeostasis(GO:0072507) |
1.4 | 10.0 | GO:0009607 | response to biotic stimulus(GO:0009607) |
1.4 | 1.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.4 | 1.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.4 | 7.1 | GO:0050821 | protein stabilization(GO:0050821) |
1.4 | 1.4 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
1.4 | 92.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
1.4 | 2.8 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
1.4 | 1.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
1.4 | 2.8 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
1.4 | 1.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
1.4 | 4.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.3 | 2.7 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
1.3 | 2.7 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
1.3 | 4.0 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
1.3 | 1.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.3 | 132.6 | GO:0019236 | response to pheromone(GO:0019236) |
1.3 | 2.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.3 | 6.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
1.2 | 3.7 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
1.2 | 7.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
1.2 | 7.4 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
1.2 | 3.7 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
1.2 | 1.2 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.2 | 1.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.2 | 1.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.2 | 1.2 | GO:0051132 | NK T cell activation(GO:0051132) |
1.2 | 1289.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
1.2 | 1.2 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
1.1 | 5.7 | GO:0030316 | osteoclast differentiation(GO:0030316) |
1.1 | 41.1 | GO:0006954 | inflammatory response(GO:0006954) |
1.1 | 1.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
1.1 | 1.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
1.1 | 2.3 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
1.1 | 1.1 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
1.1 | 1.1 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
1.1 | 6.7 | GO:0031214 | biomineral tissue development(GO:0031214) |
1.1 | 3.3 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
1.1 | 1.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.1 | 1.1 | GO:0050957 | equilibrioception(GO:0050957) |
1.1 | 48.4 | GO:0007601 | visual perception(GO:0007601) |
1.1 | 1.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
1.1 | 1.1 | GO:0070231 | T cell apoptotic process(GO:0070231) |
1.1 | 1.1 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
1.1 | 2.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.0 | 1.0 | GO:0002699 | positive regulation of immune effector process(GO:0002699) |
1.0 | 1.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.0 | 36.3 | GO:0007605 | sensory perception of sound(GO:0007605) |
1.0 | 1.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.0 | 3.1 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
1.0 | 24.4 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
1.0 | 6.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
1.0 | 2.0 | GO:0031647 | regulation of protein stability(GO:0031647) |
1.0 | 3.9 | GO:0033344 | cholesterol efflux(GO:0033344) |
1.0 | 2.9 | GO:0010469 | regulation of receptor activity(GO:0010469) |
1.0 | 1.0 | GO:0032635 | interleukin-6 production(GO:0032635) |
1.0 | 1.9 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.9 | 0.9 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.9 | 0.9 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.9 | 1.8 | GO:0033059 | cellular pigmentation(GO:0033059) |
0.9 | 1.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.9 | 0.9 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.9 | 1.8 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.9 | 0.9 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.9 | 0.9 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.9 | 0.9 | GO:0032094 | response to food(GO:0032094) |
0.9 | 0.9 | GO:0002385 | mucosal immune response(GO:0002385) |
0.9 | 0.9 | GO:0021782 | glial cell development(GO:0021782) |
0.9 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.8 | 1.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.8 | 3.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.8 | 28.9 | GO:0006952 | defense response(GO:0006952) |
0.8 | 3.3 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.8 | 0.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.8 | 0.8 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.8 | 3.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.8 | 0.8 | GO:0046683 | response to organophosphorus(GO:0046683) |
0.8 | 10.1 | GO:0006959 | humoral immune response(GO:0006959) |
0.8 | 1.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.8 | 7.7 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.8 | 1.5 | GO:0001757 | somite specification(GO:0001757) |
0.8 | 1.5 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.7 | 2.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.7 | 0.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.7 | 2.2 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.7 | 0.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.7 | 10.0 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.7 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.7 | 0.7 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) |
0.7 | 36.9 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.7 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.7 | 658.3 | GO:0097659 | nucleic acid-templated transcription(GO:0097659) |
0.7 | 0.7 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.7 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 0.7 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.6 | 1.9 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.6 | 34.4 | GO:0006897 | endocytosis(GO:0006897) |
0.6 | 0.6 | GO:0014827 | phasic smooth muscle contraction(GO:0014821) intestine smooth muscle contraction(GO:0014827) |
0.6 | 0.6 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.6 | 0.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.6 | 3.0 | GO:0044782 | cilium organization(GO:0044782) |
0.6 | 0.6 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.6 | 2.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.6 | 13.9 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.6 | 0.6 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.6 | 0.6 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.6 | 1.1 | GO:1903115 | regulation of actin filament-based movement(GO:1903115) |
0.6 | 3.3 | GO:0051180 | vitamin transport(GO:0051180) |
0.5 | 8.5 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.5 | 1.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.5 | 105.7 | GO:0006508 | proteolysis(GO:0006508) |
0.5 | 42.0 | GO:0005975 | carbohydrate metabolic process(GO:0005975) |
0.5 | 0.5 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.5 | 0.5 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.5 | 0.5 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 4.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 61.4 | GO:0055085 | transmembrane transport(GO:0055085) |
0.4 | 0.4 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.3 | 0.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.3 | 0.3 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.3 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 0.3 | GO:0060443 | mammary gland morphogenesis(GO:0060443) |
0.3 | 3.9 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.3 | 0.3 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.3 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.2 | GO:0032528 | microvillus organization(GO:0032528) |
0.2 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.2 | GO:0006576 | cellular biogenic amine metabolic process(GO:0006576) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 6.9 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.1 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.1 | 0.5 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 0.9 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
101.1 | 505.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
92.9 | 557.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
81.1 | 81.1 | GO:0032587 | ruffle membrane(GO:0032587) |
71.3 | 213.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
56.9 | 170.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
54.9 | 219.5 | GO:1990130 | Iml1 complex(GO:1990130) |
45.9 | 275.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
40.4 | 121.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
37.6 | 225.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
37.0 | 111.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
36.5 | 109.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
35.8 | 71.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
32.4 | 97.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
31.9 | 63.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
31.5 | 126.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
31.5 | 157.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
29.7 | 89.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
29.7 | 118.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
29.5 | 177.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
29.4 | 235.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
28.7 | 287.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
28.7 | 200.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
28.7 | 315.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
28.2 | 423.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
28.0 | 251.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
26.5 | 132.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
25.1 | 75.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
25.0 | 275.0 | GO:0031143 | pseudopodium(GO:0031143) |
24.4 | 195.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
24.2 | 120.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
23.9 | 95.6 | GO:0033269 | internode region of axon(GO:0033269) |
23.4 | 140.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
22.5 | 67.6 | GO:0005745 | m-AAA complex(GO:0005745) |
22.4 | 112.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
22.4 | 291.1 | GO:0036038 | MKS complex(GO:0036038) |
22.4 | 178.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
22.3 | 201.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
22.1 | 88.5 | GO:0070545 | PeBoW complex(GO:0070545) |
22.0 | 66.0 | GO:0097413 | Lewy body(GO:0097413) |
21.7 | 173.4 | GO:0043203 | axon hillock(GO:0043203) |
21.5 | 64.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
21.3 | 127.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
21.2 | 1529.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
21.1 | 506.5 | GO:0097228 | sperm principal piece(GO:0097228) |
20.4 | 81.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
20.3 | 81.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
19.8 | 871.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
19.7 | 434.1 | GO:0090544 | BAF-type complex(GO:0090544) |
19.7 | 78.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
19.5 | 97.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
19.5 | 78.1 | GO:0035339 | SPOTS complex(GO:0035339) |
19.4 | 58.1 | GO:0000811 | GINS complex(GO:0000811) |
19.3 | 58.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
19.3 | 57.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
19.2 | 38.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
19.2 | 172.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
19.0 | 57.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
18.8 | 18.8 | GO:0097422 | tubular endosome(GO:0097422) |
18.7 | 168.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
18.6 | 464.3 | GO:0008305 | integrin complex(GO:0008305) |
18.5 | 129.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
18.2 | 91.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
18.2 | 401.0 | GO:0031941 | filamentous actin(GO:0031941) |
18.1 | 54.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
18.1 | 54.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
17.9 | 89.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
17.8 | 106.9 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
17.8 | 177.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
17.7 | 300.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
17.6 | 335.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
17.6 | 52.9 | GO:0071437 | invadopodium(GO:0071437) |
17.5 | 17.5 | GO:0005903 | brush border(GO:0005903) |
17.4 | 52.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
16.9 | 16.9 | GO:0034709 | methylosome(GO:0034709) |
16.8 | 50.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
16.8 | 50.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
16.8 | 385.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
16.4 | 65.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
16.4 | 16.4 | GO:1990423 | RZZ complex(GO:1990423) |
16.3 | 32.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
16.1 | 145.0 | GO:0005869 | dynactin complex(GO:0005869) |
16.0 | 256.4 | GO:0000145 | exocyst(GO:0000145) |
15.9 | 366.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
15.9 | 79.4 | GO:0005827 | polar microtubule(GO:0005827) |
15.9 | 79.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
15.7 | 110.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
15.7 | 220.1 | GO:0097440 | apical dendrite(GO:0097440) |
15.6 | 62.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
15.5 | 31.0 | GO:0089701 | U2AF(GO:0089701) |
15.5 | 123.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
15.4 | 138.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
15.2 | 15.2 | GO:0031523 | Myb complex(GO:0031523) |
15.2 | 15.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
15.1 | 136.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
15.1 | 30.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
15.0 | 150.1 | GO:0008278 | cohesin complex(GO:0008278) |
15.0 | 45.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
15.0 | 59.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
15.0 | 59.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
14.8 | 133.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
14.7 | 14.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
14.6 | 102.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
14.5 | 43.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
14.5 | 58.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
14.5 | 43.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
14.4 | 14.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
14.2 | 71.2 | GO:0043198 | dendritic shaft(GO:0043198) |
14.2 | 28.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
14.2 | 42.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
14.1 | 28.2 | GO:0097542 | ciliary tip(GO:0097542) |
14.0 | 98.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
14.0 | 42.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
13.8 | 800.3 | GO:0005795 | Golgi stack(GO:0005795) |
13.7 | 54.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
13.6 | 40.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
13.6 | 40.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
13.6 | 40.7 | GO:1990923 | PET complex(GO:1990923) |
13.6 | 230.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
13.5 | 108.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
13.4 | 53.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
13.4 | 67.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
13.4 | 174.5 | GO:0034704 | calcium channel complex(GO:0034704) |
13.4 | 147.1 | GO:0005652 | nuclear lamina(GO:0005652) |
13.3 | 53.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
13.2 | 79.2 | GO:0071986 | Ragulator complex(GO:0071986) |
13.1 | 92.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
13.1 | 52.4 | GO:0071439 | clathrin complex(GO:0071439) |
13.1 | 39.3 | GO:1990462 | omegasome(GO:1990462) |
13.0 | 52.0 | GO:0043073 | germ cell nucleus(GO:0043073) |
13.0 | 91.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
12.9 | 90.6 | GO:0031931 | TORC1 complex(GO:0031931) |
12.8 | 89.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
12.8 | 64.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
12.8 | 127.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
12.7 | 12.7 | GO:0042827 | platelet dense granule(GO:0042827) |
12.7 | 50.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
12.7 | 76.1 | GO:0031415 | NatA complex(GO:0031415) |
12.7 | 721.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
12.6 | 529.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
12.5 | 311.5 | GO:0005771 | multivesicular body(GO:0005771) |
12.3 | 98.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
12.2 | 440.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
12.2 | 36.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
12.2 | 219.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
12.2 | 133.8 | GO:0031528 | microvillus membrane(GO:0031528) |
12.1 | 398.3 | GO:0016592 | mediator complex(GO:0016592) |
12.0 | 83.9 | GO:0042382 | paraspeckles(GO:0042382) |
12.0 | 24.0 | GO:0044327 | dendritic spine head(GO:0044327) |
11.9 | 23.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
11.9 | 143.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
11.9 | 107.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
11.9 | 35.6 | GO:0005914 | spot adherens junction(GO:0005914) |
11.8 | 59.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
11.8 | 129.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
11.7 | 23.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
11.7 | 35.0 | GO:0016939 | kinesin II complex(GO:0016939) |
11.7 | 81.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
11.6 | 93.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
11.6 | 34.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
11.6 | 57.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
11.6 | 138.7 | GO:0042581 | specific granule(GO:0042581) |
11.5 | 276.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
11.5 | 115.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
11.5 | 11.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
11.5 | 22.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
11.4 | 125.4 | GO:0044292 | dendrite terminus(GO:0044292) |
11.4 | 11.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
11.4 | 34.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
11.3 | 260.4 | GO:0005776 | autophagosome(GO:0005776) |
11.3 | 45.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
11.3 | 33.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
11.2 | 11.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
11.2 | 22.4 | GO:0032584 | growth cone membrane(GO:0032584) |
11.2 | 55.9 | GO:0035859 | Seh1-associated complex(GO:0035859) |
11.2 | 100.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
11.2 | 11.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
11.1 | 33.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
11.1 | 475.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
11.0 | 11.0 | GO:0045178 | basal part of cell(GO:0045178) |
11.0 | 131.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
11.0 | 131.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
11.0 | 109.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
10.9 | 10.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
10.9 | 10.9 | GO:0043219 | lateral loop(GO:0043219) |
10.9 | 76.1 | GO:0033263 | CORVET complex(GO:0033263) |
10.8 | 32.5 | GO:0001650 | fibrillar center(GO:0001650) |
10.8 | 216.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
10.8 | 172.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
10.7 | 10.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
10.7 | 21.4 | GO:0005642 | annulate lamellae(GO:0005642) |
10.6 | 10.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
10.6 | 42.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
10.6 | 180.0 | GO:0000242 | pericentriolar material(GO:0000242) |
10.6 | 105.7 | GO:0016235 | aggresome(GO:0016235) |
10.6 | 337.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
10.4 | 83.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
10.4 | 41.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
10.4 | 72.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
10.3 | 20.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
10.3 | 41.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
10.3 | 113.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
10.3 | 185.2 | GO:0030904 | retromer complex(GO:0030904) |
10.3 | 41.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
10.2 | 71.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
10.2 | 10.2 | GO:0033270 | paranode region of axon(GO:0033270) |
10.2 | 20.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
10.1 | 30.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
10.1 | 241.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
10.1 | 20.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
10.1 | 502.9 | GO:0042641 | actomyosin(GO:0042641) |
10.0 | 421.2 | GO:0016363 | nuclear matrix(GO:0016363) |
10.0 | 30.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
9.9 | 169.0 | GO:0034451 | centriolar satellite(GO:0034451) |
9.9 | 128.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
9.8 | 39.3 | GO:0097452 | GAIT complex(GO:0097452) |
9.8 | 88.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
9.8 | 540.0 | GO:0016605 | PML body(GO:0016605) |
9.8 | 48.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
9.8 | 303.1 | GO:0098791 | Golgi subcompartment(GO:0098791) |
9.7 | 58.3 | GO:0030894 | replisome(GO:0030894) |
9.6 | 77.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
9.6 | 38.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
9.6 | 19.2 | GO:0000791 | euchromatin(GO:0000791) |
9.6 | 9.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
9.6 | 641.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
9.6 | 105.2 | GO:0002102 | podosome(GO:0002102) |
9.5 | 56.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
9.4 | 28.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
9.4 | 75.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
9.4 | 28.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
9.3 | 56.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
9.3 | 503.6 | GO:0000502 | proteasome complex(GO:0000502) |
9.3 | 27.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
9.3 | 27.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
9.3 | 120.6 | GO:0010369 | chromocenter(GO:0010369) |
9.3 | 27.8 | GO:0031430 | M band(GO:0031430) |
9.3 | 333.3 | GO:0005643 | nuclear pore(GO:0005643) |
9.2 | 92.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
9.2 | 82.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
9.1 | 200.7 | GO:0001772 | immunological synapse(GO:0001772) |
9.1 | 27.4 | GO:0042583 | chromaffin granule(GO:0042583) |
9.0 | 903.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
9.0 | 45.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
9.0 | 234.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
9.0 | 45.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
9.0 | 62.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
9.0 | 44.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
9.0 | 18.0 | GO:0030870 | Mre11 complex(GO:0030870) |
9.0 | 71.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
9.0 | 26.9 | GO:0000346 | transcription export complex(GO:0000346) |
8.9 | 26.8 | GO:0005955 | calcineurin complex(GO:0005955) |
8.9 | 8.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
8.9 | 124.1 | GO:0043205 | fibril(GO:0043205) |
8.8 | 70.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
8.8 | 79.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
8.8 | 35.1 | GO:0000796 | condensin complex(GO:0000796) |
8.7 | 96.1 | GO:0032039 | integrator complex(GO:0032039) |
8.7 | 8.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
8.7 | 26.0 | GO:0097443 | sorting endosome(GO:0097443) |
8.6 | 102.7 | GO:0005876 | spindle microtubule(GO:0005876) |
8.5 | 68.3 | GO:0070652 | HAUS complex(GO:0070652) |
8.5 | 8.5 | GO:0097470 | ribbon synapse(GO:0097470) |
8.5 | 25.5 | GO:0070938 | contractile ring(GO:0070938) |
8.5 | 25.5 | GO:0000805 | X chromosome(GO:0000805) |
8.5 | 50.9 | GO:0034464 | BBSome(GO:0034464) |
8.5 | 110.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
8.5 | 25.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
8.5 | 2258.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
8.5 | 42.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
8.4 | 405.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
8.4 | 59.0 | GO:0031090 | organelle membrane(GO:0031090) |
8.4 | 58.9 | GO:0060091 | kinocilium(GO:0060091) |
8.4 | 16.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
8.4 | 16.8 | GO:0001739 | sex chromatin(GO:0001739) |
8.3 | 191.9 | GO:0055037 | recycling endosome(GO:0055037) |
8.3 | 83.2 | GO:0031011 | Ino80 complex(GO:0031011) |
8.3 | 66.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
8.3 | 74.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
8.3 | 91.0 | GO:0030914 | STAGA complex(GO:0030914) |
8.2 | 99.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
8.2 | 49.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
8.2 | 32.9 | GO:0001891 | phagocytic cup(GO:0001891) |
8.2 | 1010.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
8.2 | 16.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
8.2 | 90.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
8.2 | 146.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
8.1 | 16.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
8.1 | 24.2 | GO:0000974 | Prp19 complex(GO:0000974) |
8.1 | 16.1 | GO:0043218 | compact myelin(GO:0043218) |
8.0 | 176.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
8.0 | 16.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
8.0 | 88.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
8.0 | 16.0 | GO:0044309 | neuron spine(GO:0044309) |
7.9 | 71.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
7.9 | 23.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
7.9 | 79.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
7.9 | 8618.4 | GO:0005829 | cytosol(GO:0005829) |
7.9 | 182.0 | GO:0012505 | endomembrane system(GO:0012505) |
7.8 | 15.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
7.8 | 195.2 | GO:0031201 | SNARE complex(GO:0031201) |
7.8 | 62.2 | GO:0033391 | chromatoid body(GO:0033391) |
7.7 | 15.5 | GO:0005687 | U4 snRNP(GO:0005687) |
7.7 | 77.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
7.7 | 15.4 | GO:0033268 | node of Ranvier(GO:0033268) |
7.7 | 15.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
7.6 | 7.6 | GO:0005686 | U2 snRNP(GO:0005686) |
7.6 | 114.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
7.6 | 15.2 | GO:0030056 | hemidesmosome(GO:0030056) |
7.6 | 30.5 | GO:0031932 | TORC2 complex(GO:0031932) |
7.6 | 30.4 | GO:1990745 | EARP complex(GO:1990745) |
7.6 | 22.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
7.6 | 30.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
7.5 | 52.5 | GO:0000124 | SAGA complex(GO:0000124) |
7.5 | 67.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
7.5 | 7.5 | GO:0071010 | prespliceosome(GO:0071010) |
7.4 | 22.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
7.4 | 14.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
7.4 | 296.2 | GO:0000793 | condensed chromosome(GO:0000793) |
7.4 | 96.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
7.4 | 14.7 | GO:0097255 | R2TP complex(GO:0097255) |
7.3 | 14.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
7.3 | 14.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
7.3 | 58.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
7.2 | 14.5 | GO:0051233 | spindle midzone(GO:0051233) |
7.2 | 144.3 | GO:0031519 | PcG protein complex(GO:0031519) |
7.1 | 56.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
7.1 | 14.2 | GO:0070469 | respiratory chain(GO:0070469) |
7.1 | 28.4 | GO:0016600 | flotillin complex(GO:0016600) |
7.1 | 262.3 | GO:0016459 | myosin complex(GO:0016459) |
7.1 | 77.8 | GO:0035861 | site of double-strand break(GO:0035861) |
7.1 | 21.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
7.1 | 28.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
7.0 | 337.4 | GO:0044440 | endosomal part(GO:0044440) |
7.0 | 7.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
7.0 | 13.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
6.9 | 145.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
6.9 | 7399.9 | GO:0005654 | nucleoplasm(GO:0005654) |
6.9 | 13.8 | GO:0098536 | deuterosome(GO:0098536) |
6.9 | 20.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
6.9 | 178.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
6.9 | 479.8 | GO:0072562 | blood microparticle(GO:0072562) |
6.8 | 40.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
6.8 | 40.8 | GO:0030880 | RNA polymerase complex(GO:0030880) |
6.8 | 27.2 | GO:0005796 | Golgi lumen(GO:0005796) |
6.7 | 13.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
6.7 | 20.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
6.6 | 1574.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
6.6 | 39.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
6.5 | 418.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
6.5 | 632.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
6.5 | 103.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
6.5 | 45.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
6.4 | 530.6 | GO:0000139 | Golgi membrane(GO:0000139) |
6.4 | 370.8 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
6.4 | 6.4 | GO:0043209 | myelin sheath(GO:0043209) |
6.3 | 38.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
6.3 | 12.6 | GO:0030689 | Noc complex(GO:0030689) |
6.3 | 200.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
6.2 | 3811.5 | GO:0005739 | mitochondrion(GO:0005739) |
6.2 | 6.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
6.2 | 24.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
6.1 | 18.4 | GO:0042627 | chylomicron(GO:0042627) |
6.0 | 281.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
5.9 | 113.0 | GO:0005811 | lipid particle(GO:0005811) |
5.9 | 17.8 | GO:0031417 | NatC complex(GO:0031417) |
5.9 | 29.4 | GO:0045120 | pronucleus(GO:0045120) |
5.9 | 29.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
5.8 | 993.6 | GO:0005768 | endosome(GO:0005768) |
5.8 | 115.1 | GO:0030133 | transport vesicle(GO:0030133) |
5.6 | 73.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
5.6 | 55.8 | GO:0043034 | costamere(GO:0043034) |
5.5 | 27.7 | GO:0031512 | motile primary cilium(GO:0031512) |
5.5 | 11.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
5.5 | 569.3 | GO:0031975 | envelope(GO:0031975) |
5.5 | 27.5 | GO:0030057 | desmosome(GO:0030057) |
5.5 | 5.5 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) INO80-type complex(GO:0097346) |
5.5 | 32.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
5.5 | 16.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
5.5 | 480.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
5.5 | 158.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
5.4 | 147.1 | GO:0034707 | chloride channel complex(GO:0034707) |
5.4 | 140.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
5.4 | 475.7 | GO:1990234 | transferase complex(GO:1990234) |
5.3 | 5.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
5.3 | 10.5 | GO:0001520 | outer dense fiber(GO:0001520) |
5.2 | 5.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
5.2 | 1491.6 | GO:0005794 | Golgi apparatus(GO:0005794) |
5.1 | 81.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
5.1 | 71.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
5.1 | 15.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
5.0 | 59.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
5.0 | 24.9 | GO:0032426 | stereocilium tip(GO:0032426) |
4.9 | 819.6 | GO:0098552 | side of membrane(GO:0098552) |
4.9 | 9.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
4.9 | 3058.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
4.9 | 111.7 | GO:0042383 | sarcolemma(GO:0042383) |
4.8 | 92.0 | GO:0005929 | cilium(GO:0005929) |
4.8 | 435.3 | GO:0005667 | transcription factor complex(GO:0005667) |
4.8 | 4.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
4.8 | 4.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
4.8 | 47.6 | GO:0043234 | protein complex(GO:0043234) |
4.8 | 14.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
4.7 | 4.7 | GO:0001652 | granular component(GO:0001652) |
4.6 | 55.6 | GO:0005844 | polysome(GO:0005844) |
4.6 | 9.3 | GO:0005840 | ribosome(GO:0005840) |
4.6 | 4.6 | GO:0044299 | C-fiber(GO:0044299) |
4.6 | 41.3 | GO:0015629 | actin cytoskeleton(GO:0015629) |
4.5 | 2531.7 | GO:0031982 | vesicle(GO:0031982) |
4.5 | 107.6 | GO:0000228 | nuclear chromosome(GO:0000228) |
4.5 | 53.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
4.5 | 476.9 | GO:0005874 | microtubule(GO:0005874) |
4.3 | 4.3 | GO:0016528 | sarcoplasm(GO:0016528) |
4.2 | 63.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
4.2 | 223.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
4.2 | 4.2 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
4.1 | 4.1 | GO:0005875 | microtubule associated complex(GO:0005875) |
4.1 | 53.2 | GO:0000922 | spindle pole(GO:0000922) |
4.0 | 9430.4 | GO:0005737 | cytoplasm(GO:0005737) |
4.0 | 32.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
3.9 | 3.9 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
3.7 | 3.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
3.7 | 7.4 | GO:0097225 | sperm midpiece(GO:0097225) |
3.6 | 21.8 | GO:0043204 | perikaryon(GO:0043204) |
3.6 | 3.6 | GO:0044297 | cell body(GO:0044297) |
3.6 | 18.0 | GO:0097223 | sperm part(GO:0097223) |
3.4 | 44.1 | GO:0098793 | presynapse(GO:0098793) |
3.4 | 10.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
3.3 | 9.9 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
3.3 | 6.5 | GO:0042555 | MCM complex(GO:0042555) |
3.3 | 74.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
3.2 | 413.3 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
3.2 | 6.3 | GO:1902494 | catalytic complex(GO:1902494) |
3.2 | 22.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
3.1 | 40.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
3.1 | 65.0 | GO:0005694 | chromosome(GO:0005694) |
3.0 | 3208.3 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
2.9 | 5.9 | GO:0032420 | stereocilium(GO:0032420) |
2.9 | 327.3 | GO:0009986 | cell surface(GO:0009986) |
2.9 | 2255.0 | GO:0005576 | extracellular region(GO:0005576) |
2.8 | 39.8 | GO:0005922 | connexon complex(GO:0005922) |
2.8 | 3025.6 | GO:0005886 | plasma membrane(GO:0005886) |
2.6 | 4098.8 | GO:0016020 | membrane(GO:0016020) |
2.4 | 259.8 | GO:0005622 | intracellular(GO:0005622) |
1.8 | 9.2 | GO:0097458 | neuron part(GO:0097458) |
1.8 | 25.2 | GO:0005623 | cell(GO:0005623) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
126.0 | 504.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
94.0 | 376.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
85.3 | 597.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
81.7 | 81.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
81.1 | 243.3 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
80.7 | 322.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
79.7 | 318.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
79.2 | 237.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
65.5 | 196.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
62.5 | 250.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
61.3 | 245.2 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
56.0 | 112.0 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
55.7 | 389.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
54.7 | 273.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
53.0 | 159.1 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
52.5 | 157.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
50.8 | 152.3 | GO:0004064 | arylesterase activity(GO:0004064) |
48.4 | 145.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
48.2 | 144.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
47.8 | 143.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
47.2 | 188.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
47.1 | 188.6 | GO:0009374 | biotin binding(GO:0009374) |
43.0 | 258.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
42.7 | 128.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
42.0 | 839.2 | GO:0030506 | ankyrin binding(GO:0030506) |
41.7 | 125.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
41.3 | 41.3 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
40.7 | 81.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
40.6 | 324.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
40.2 | 160.8 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
39.3 | 274.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
38.6 | 154.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
38.4 | 38.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
38.0 | 190.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
37.7 | 113.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
37.2 | 334.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
36.9 | 147.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
36.6 | 292.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
35.7 | 71.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
35.5 | 71.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
34.6 | 242.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
34.2 | 171.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
33.9 | 33.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
33.6 | 100.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
33.4 | 100.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
33.3 | 166.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
33.3 | 199.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
33.1 | 99.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
33.1 | 132.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
32.1 | 192.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
32.0 | 64.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
32.0 | 159.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
31.8 | 95.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
31.6 | 63.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
31.1 | 249.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
30.9 | 92.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
30.2 | 90.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
30.0 | 360.5 | GO:0016208 | AMP binding(GO:0016208) |
29.8 | 89.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
29.6 | 177.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
28.9 | 231.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
28.6 | 28.6 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
28.5 | 56.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
28.2 | 84.7 | GO:0019961 | interferon binding(GO:0019961) |
28.2 | 56.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
28.1 | 56.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
27.5 | 109.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
27.3 | 354.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
27.1 | 108.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
26.8 | 134.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
26.8 | 214.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
26.4 | 26.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
26.2 | 78.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
26.2 | 340.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
26.1 | 78.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
25.7 | 51.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
25.2 | 176.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
25.1 | 150.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
25.0 | 50.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
24.8 | 74.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
24.6 | 221.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
24.6 | 836.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
24.2 | 24.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
24.2 | 72.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
24.2 | 145.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
24.1 | 120.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
24.1 | 72.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
23.6 | 70.8 | GO:2001070 | starch binding(GO:2001070) |
23.6 | 188.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
23.6 | 70.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
23.5 | 211.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
23.5 | 164.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
23.4 | 23.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
23.3 | 209.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
23.3 | 93.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
23.3 | 93.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
23.2 | 208.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
22.9 | 45.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
22.9 | 205.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
22.8 | 68.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
22.6 | 67.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
22.3 | 111.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
22.1 | 88.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
22.0 | 44.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
22.0 | 66.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
22.0 | 65.9 | GO:0051425 | PTB domain binding(GO:0051425) |
21.7 | 282.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
21.6 | 64.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
21.6 | 64.8 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
21.6 | 86.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
21.3 | 21.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
21.2 | 84.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
21.1 | 147.7 | GO:0046790 | virion binding(GO:0046790) |
21.0 | 63.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
21.0 | 63.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
20.8 | 62.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
20.7 | 82.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
20.7 | 82.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
20.5 | 61.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
20.3 | 61.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
20.1 | 100.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
20.0 | 80.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
20.0 | 99.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
19.9 | 79.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
19.9 | 297.8 | GO:0005521 | lamin binding(GO:0005521) |
19.8 | 39.7 | GO:0004096 | catalase activity(GO:0004096) |
19.8 | 79.2 | GO:0043559 | insulin binding(GO:0043559) |
19.8 | 39.6 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
19.5 | 78.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
19.4 | 19.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
19.3 | 57.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
19.2 | 77.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
19.2 | 172.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
19.0 | 56.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
18.9 | 56.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
18.6 | 540.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
18.5 | 203.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
18.5 | 55.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
18.5 | 73.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
18.4 | 36.8 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
18.3 | 36.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
18.2 | 54.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
18.1 | 72.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
17.9 | 322.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
17.9 | 53.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
17.9 | 428.5 | GO:0045502 | dynein binding(GO:0045502) |
17.8 | 267.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
17.8 | 53.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
17.8 | 266.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
17.7 | 53.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
17.7 | 88.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
17.7 | 70.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
17.7 | 35.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
17.6 | 176.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
17.6 | 87.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
17.6 | 70.2 | GO:0050693 | LBD domain binding(GO:0050693) |
17.5 | 35.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
17.5 | 87.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
17.4 | 364.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
17.3 | 414.3 | GO:0030507 | spectrin binding(GO:0030507) |
17.2 | 137.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
17.1 | 68.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
17.1 | 51.3 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
17.1 | 51.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
17.0 | 119.3 | GO:0018638 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
17.0 | 118.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
16.9 | 101.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
16.9 | 16.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
16.8 | 67.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
16.8 | 50.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
16.8 | 50.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
16.8 | 268.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
16.7 | 50.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
16.4 | 32.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
16.3 | 456.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
16.3 | 341.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
16.2 | 48.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
16.1 | 128.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
16.1 | 144.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
15.9 | 95.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
15.9 | 15.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
15.8 | 79.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
15.8 | 110.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
15.8 | 63.1 | GO:0015232 | heme transporter activity(GO:0015232) |
15.6 | 78.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
15.6 | 46.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
15.6 | 93.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
15.5 | 15.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
15.4 | 46.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
15.4 | 138.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
15.4 | 138.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
15.3 | 91.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
15.3 | 45.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
15.2 | 121.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
15.2 | 45.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
15.1 | 60.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
15.1 | 136.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
15.1 | 120.5 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
15.0 | 45.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
15.0 | 194.8 | GO:0010181 | FMN binding(GO:0010181) |
15.0 | 15.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
14.9 | 89.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
14.9 | 44.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
14.8 | 147.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
14.7 | 58.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
14.7 | 14.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
14.5 | 58.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
14.5 | 43.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
14.5 | 159.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
14.5 | 87.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
14.5 | 57.9 | GO:0038100 | nodal binding(GO:0038100) |
14.4 | 173.4 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
14.4 | 43.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
14.4 | 100.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
14.2 | 71.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
14.2 | 71.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
14.2 | 42.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
14.2 | 14.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
14.2 | 155.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
14.1 | 14.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
14.1 | 254.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
14.1 | 42.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
14.1 | 155.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
14.1 | 42.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
14.0 | 14.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
14.0 | 42.0 | GO:0030984 | kininogen binding(GO:0030984) |
14.0 | 265.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
13.9 | 41.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
13.8 | 55.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
13.8 | 69.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
13.8 | 55.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
13.8 | 55.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
13.8 | 41.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
13.8 | 151.6 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
13.7 | 68.7 | GO:0016151 | nickel cation binding(GO:0016151) |
13.7 | 54.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
13.7 | 68.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
13.6 | 422.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
13.6 | 245.0 | GO:0008483 | transaminase activity(GO:0008483) |
13.5 | 54.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
13.5 | 13.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
13.5 | 54.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
13.5 | 53.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
13.5 | 53.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
13.4 | 40.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
13.4 | 66.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
13.4 | 53.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
13.2 | 238.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
13.2 | 39.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
13.1 | 552.3 | GO:0043022 | ribosome binding(GO:0043022) |
13.1 | 39.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
13.1 | 183.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
13.1 | 157.0 | GO:0070628 | proteasome binding(GO:0070628) |
13.0 | 129.5 | GO:0004568 | chitinase activity(GO:0004568) |
12.9 | 77.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
12.9 | 12.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
12.9 | 25.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
12.9 | 51.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
12.8 | 64.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
12.8 | 25.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
12.8 | 102.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
12.8 | 242.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
12.8 | 191.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
12.6 | 341.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
12.6 | 366.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
12.6 | 25.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
12.6 | 62.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
12.6 | 364.7 | GO:0050699 | WW domain binding(GO:0050699) |
12.6 | 25.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
12.5 | 125.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
12.5 | 25.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
12.5 | 112.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
12.4 | 124.4 | GO:0001618 | virus receptor activity(GO:0001618) |
12.4 | 272.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
12.4 | 136.2 | GO:0030955 | potassium ion binding(GO:0030955) |
12.4 | 49.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
12.4 | 61.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
12.3 | 49.4 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
12.3 | 37.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
12.3 | 73.7 | GO:0050733 | RS domain binding(GO:0050733) |
12.3 | 233.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
12.3 | 49.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
12.3 | 24.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
12.3 | 73.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
12.2 | 134.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
12.2 | 219.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
12.2 | 109.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
12.1 | 109.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
12.1 | 121.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
12.1 | 156.8 | GO:0015928 | fucosidase activity(GO:0015928) |
12.1 | 24.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
12.0 | 204.4 | GO:0043531 | ADP binding(GO:0043531) |
12.0 | 35.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
11.9 | 238.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
11.9 | 71.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
11.9 | 59.4 | GO:0070728 | leucine binding(GO:0070728) |
11.8 | 47.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
11.8 | 106.0 | GO:0039706 | co-receptor binding(GO:0039706) |
11.7 | 493.0 | GO:0019209 | kinase activator activity(GO:0019209) |
11.7 | 152.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
11.7 | 23.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
11.6 | 69.6 | GO:0030274 | LIM domain binding(GO:0030274) |
11.6 | 34.7 | GO:0000339 | RNA cap binding(GO:0000339) |
11.6 | 11.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
11.5 | 92.3 | GO:0043176 | amine binding(GO:0043176) |
11.5 | 11.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
11.5 | 298.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
11.4 | 57.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
11.4 | 159.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
11.3 | 34.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
11.3 | 33.9 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
11.3 | 33.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
11.3 | 112.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
11.2 | 33.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
11.2 | 33.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
11.2 | 550.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
11.2 | 179.6 | GO:0001848 | complement binding(GO:0001848) |
11.2 | 56.1 | GO:0017040 | ceramidase activity(GO:0017040) |
11.2 | 100.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
11.2 | 22.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
11.2 | 368.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
11.2 | 44.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
11.1 | 244.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
11.1 | 111.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
11.1 | 33.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
11.1 | 199.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
11.1 | 11.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
11.0 | 66.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
11.0 | 109.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
11.0 | 54.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
10.9 | 32.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
10.9 | 568.5 | GO:0051087 | chaperone binding(GO:0051087) |
10.9 | 43.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
10.9 | 32.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
10.9 | 98.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
10.9 | 43.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
10.9 | 21.8 | GO:0070538 | oleic acid binding(GO:0070538) |
10.9 | 32.6 | GO:0030911 | TPR domain binding(GO:0030911) |
10.8 | 97.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
10.8 | 53.8 | GO:0015288 | porin activity(GO:0015288) |
10.7 | 75.2 | GO:0034046 | poly(G) binding(GO:0034046) |
10.7 | 128.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
10.7 | 32.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
10.7 | 64.1 | GO:0000150 | recombinase activity(GO:0000150) |
10.7 | 21.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
10.7 | 224.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
10.7 | 128.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
10.7 | 32.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
10.7 | 10.7 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
10.7 | 42.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
10.6 | 159.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
10.6 | 42.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
10.6 | 159.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
10.6 | 127.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
10.5 | 10.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
10.5 | 263.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
10.5 | 31.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
10.5 | 168.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
10.5 | 73.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
10.5 | 21.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
10.5 | 73.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
10.5 | 303.4 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
10.4 | 41.8 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
10.4 | 73.1 | GO:0008430 | selenium binding(GO:0008430) |
10.4 | 31.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
10.4 | 93.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
10.4 | 20.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
10.3 | 51.5 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
10.3 | 10.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
10.3 | 925.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
10.2 | 41.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
10.2 | 40.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
10.2 | 20.5 | GO:0035877 | death effector domain binding(GO:0035877) |
10.2 | 30.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
10.2 | 81.3 | GO:0005123 | death receptor binding(GO:0005123) |
10.1 | 172.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
10.1 | 30.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
10.1 | 90.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
10.1 | 655.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
10.0 | 70.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
10.0 | 40.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
10.0 | 837.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
10.0 | 29.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
10.0 | 119.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
9.9 | 129.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
9.9 | 49.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
9.9 | 9.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
9.9 | 79.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
9.9 | 9.9 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
9.9 | 9.9 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
9.9 | 9.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
9.9 | 39.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
9.9 | 49.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
9.8 | 29.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
9.8 | 19.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
9.8 | 392.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
9.8 | 49.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
9.8 | 78.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
9.8 | 29.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
9.7 | 29.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
9.7 | 272.1 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
9.7 | 77.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
9.7 | 125.7 | GO:0008143 | poly(A) binding(GO:0008143) |
9.6 | 57.8 | GO:0005113 | patched binding(GO:0005113) |
9.6 | 86.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
9.6 | 9.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
9.6 | 325.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
9.5 | 105.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
9.5 | 28.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
9.5 | 28.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
9.5 | 38.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
9.5 | 66.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
9.5 | 56.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
9.5 | 56.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
9.5 | 37.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
9.4 | 113.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
9.4 | 9.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
9.4 | 56.5 | GO:0045545 | syndecan binding(GO:0045545) |
9.4 | 206.4 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
9.4 | 9.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
9.3 | 112.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
9.3 | 74.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
9.3 | 46.6 | GO:0071949 | FAD binding(GO:0071949) |
9.3 | 612.4 | GO:0008565 | protein transporter activity(GO:0008565) |
9.3 | 74.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
9.2 | 83.0 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
9.1 | 9.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
9.1 | 18.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
9.1 | 9.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
9.1 | 54.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
9.1 | 54.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
9.1 | 36.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
9.0 | 18.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
9.0 | 27.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
9.0 | 449.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
9.0 | 36.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
9.0 | 35.9 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
9.0 | 26.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
9.0 | 44.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
9.0 | 9.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
8.9 | 80.5 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
8.9 | 17.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
8.9 | 115.8 | GO:0015026 | coreceptor activity(GO:0015026) |
8.9 | 79.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
8.8 | 17.7 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
8.8 | 35.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
8.8 | 61.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
8.8 | 35.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
8.7 | 43.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
8.7 | 8.7 | GO:0034618 | arginine binding(GO:0034618) |
8.7 | 8.7 | GO:0008142 | oxysterol binding(GO:0008142) |
8.7 | 355.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
8.7 | 104.1 | GO:0004527 | exonuclease activity(GO:0004527) |
8.7 | 34.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
8.7 | 17.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
8.7 | 17.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
8.6 | 441.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
8.6 | 25.9 | GO:0055103 | ligase regulator activity(GO:0055103) |
8.6 | 395.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
8.6 | 8.6 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
8.6 | 8.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
8.6 | 8.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
8.6 | 25.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
8.5 | 102.5 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
8.5 | 392.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
8.5 | 25.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
8.4 | 76.0 | GO:0002039 | p53 binding(GO:0002039) |
8.4 | 16.9 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
8.4 | 75.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
8.4 | 8.4 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
8.4 | 108.6 | GO:0000049 | tRNA binding(GO:0000049) |
8.3 | 16.6 | GO:1990188 | euchromatin binding(GO:1990188) |
8.3 | 199.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
8.3 | 74.8 | GO:0019841 | retinol binding(GO:0019841) |
8.3 | 58.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
8.3 | 66.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
8.2 | 16.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
8.2 | 33.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
8.2 | 90.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
8.2 | 24.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
8.2 | 8.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
8.2 | 8.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) cyclohydrolase activity(GO:0019238) |
8.1 | 105.9 | GO:0008252 | nucleotidase activity(GO:0008252) |
8.1 | 24.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
8.1 | 16.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
8.1 | 81.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
8.1 | 40.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
8.1 | 8.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
8.1 | 32.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
8.1 | 56.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
8.0 | 40.2 | GO:1990405 | protein antigen binding(GO:1990405) |
8.0 | 16.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
8.0 | 96.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
8.0 | 56.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
8.0 | 24.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
8.0 | 40.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
8.0 | 39.9 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
8.0 | 8.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
8.0 | 477.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
7.9 | 127.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
7.9 | 7.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
7.9 | 15.8 | GO:0070061 | fructose binding(GO:0070061) |
7.9 | 39.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
7.9 | 31.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
7.9 | 196.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
7.8 | 7.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
7.8 | 23.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
7.8 | 23.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
7.8 | 62.4 | GO:0031996 | thioesterase binding(GO:0031996) |
7.7 | 30.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
7.7 | 292.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
7.7 | 23.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
7.7 | 53.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
7.6 | 137.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
7.6 | 22.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
7.6 | 76.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
7.6 | 15.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
7.6 | 38.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
7.6 | 227.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
7.6 | 30.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
7.5 | 128.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
7.5 | 37.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
7.5 | 180.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
7.5 | 22.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
7.5 | 44.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
7.4 | 81.6 | GO:0030145 | manganese ion binding(GO:0030145) |
7.4 | 14.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
7.4 | 29.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
7.4 | 22.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
7.4 | 22.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
7.4 | 51.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
7.4 | 29.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
7.3 | 51.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
7.3 | 29.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
7.3 | 219.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
7.3 | 65.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
7.3 | 349.7 | GO:0016836 | hydro-lyase activity(GO:0016836) |
7.3 | 51.0 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
7.3 | 21.8 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
7.3 | 123.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
7.2 | 14.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
7.2 | 14.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
7.1 | 14.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
7.1 | 14.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
7.1 | 299.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
7.1 | 917.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
7.1 | 14.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
7.1 | 21.3 | GO:0019213 | deacetylase activity(GO:0019213) |
7.1 | 7.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
7.1 | 28.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
7.1 | 642.7 | GO:0019902 | phosphatase binding(GO:0019902) |
7.0 | 7.0 | GO:0036033 | mediator complex binding(GO:0036033) |
7.0 | 98.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
7.0 | 132.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
7.0 | 76.6 | GO:0030552 | cAMP binding(GO:0030552) |
7.0 | 34.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
6.9 | 13.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
6.9 | 13.9 | GO:0051373 | FATZ binding(GO:0051373) |
6.9 | 97.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
6.9 | 27.6 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
6.9 | 96.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
6.8 | 27.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
6.8 | 34.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
6.8 | 81.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
6.8 | 13.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
6.8 | 183.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
6.8 | 61.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
6.8 | 115.3 | GO:0030515 | snoRNA binding(GO:0030515) |
6.8 | 6.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
6.8 | 6.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
6.7 | 33.7 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
6.7 | 13.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
6.7 | 93.7 | GO:0031489 | myosin V binding(GO:0031489) |
6.7 | 46.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
6.7 | 133.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
6.7 | 6.7 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
6.6 | 19.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
6.6 | 6.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
6.6 | 26.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
6.6 | 13.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
6.6 | 13.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
6.6 | 164.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
6.6 | 702.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
6.5 | 13.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
6.5 | 26.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
6.5 | 19.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
6.5 | 32.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
6.5 | 32.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
6.4 | 109.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
6.4 | 442.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
6.4 | 108.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
6.4 | 25.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
6.4 | 38.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
6.3 | 31.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
6.3 | 12.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
6.3 | 6.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
6.3 | 37.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
6.3 | 18.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
6.3 | 6.3 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
6.2 | 18.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
6.2 | 24.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
6.2 | 74.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
6.1 | 18.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
6.1 | 6.1 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
6.1 | 18.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
6.1 | 18.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
6.1 | 6.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
6.1 | 79.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
6.1 | 54.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
6.1 | 24.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
6.1 | 18.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
6.0 | 6.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
6.0 | 18.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
6.0 | 84.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
6.0 | 48.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
6.0 | 12.0 | GO:0000182 | rDNA binding(GO:0000182) |
6.0 | 53.9 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
6.0 | 53.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
5.9 | 77.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
5.9 | 65.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
5.9 | 17.8 | GO:0048030 | disaccharide binding(GO:0048030) |
5.9 | 11.8 | GO:0004672 | protein kinase activity(GO:0004672) |
5.9 | 65.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
5.9 | 5.9 | GO:0015197 | peptide transporter activity(GO:0015197) |
5.8 | 5.8 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
5.8 | 11.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
5.8 | 227.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
5.8 | 34.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
5.8 | 46.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
5.8 | 11.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
5.7 | 23.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
5.7 | 51.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
5.7 | 28.7 | GO:0050700 | CARD domain binding(GO:0050700) |
5.7 | 96.9 | GO:0008201 | heparin binding(GO:0008201) |
5.7 | 22.8 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
5.7 | 11.4 | GO:0016853 | isomerase activity(GO:0016853) |
5.7 | 22.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
5.7 | 11.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
5.7 | 17.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
5.7 | 5.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
5.7 | 33.9 | GO:0031386 | protein tag(GO:0031386) |
5.6 | 242.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
5.6 | 44.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
5.6 | 11.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
5.6 | 67.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
5.6 | 27.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
5.6 | 83.8 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
5.6 | 133.5 | GO:0015485 | cholesterol binding(GO:0015485) |
5.5 | 11.1 | GO:0038132 | neuregulin binding(GO:0038132) |
5.5 | 27.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
5.5 | 16.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
5.5 | 22.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
5.5 | 16.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
5.5 | 5.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
5.5 | 16.5 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
5.5 | 11.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
5.5 | 11.0 | GO:0070052 | collagen V binding(GO:0070052) |
5.5 | 54.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
5.5 | 120.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
5.4 | 5.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) Toll-like receptor 4 binding(GO:0035662) |
5.4 | 146.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
5.4 | 48.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
5.4 | 32.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
5.4 | 436.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
5.4 | 16.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
5.4 | 10.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
5.4 | 32.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
5.4 | 26.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
5.4 | 10.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
5.3 | 10.7 | GO:0043515 | kinetochore binding(GO:0043515) |
5.3 | 181.5 | GO:0004518 | nuclease activity(GO:0004518) |
5.3 | 58.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
5.3 | 26.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
5.3 | 26.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
5.3 | 37.0 | GO:0017166 | vinculin binding(GO:0017166) |
5.3 | 5.3 | GO:0030545 | receptor regulator activity(GO:0030545) |
5.3 | 152.6 | GO:0005507 | copper ion binding(GO:0005507) |
5.3 | 42.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
5.2 | 62.8 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
5.2 | 31.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
5.2 | 26.0 | GO:0005499 | vitamin D binding(GO:0005499) |
5.2 | 10.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
5.2 | 10.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
5.1 | 51.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
5.1 | 15.4 | GO:0031014 | troponin T binding(GO:0031014) |
5.1 | 5.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
5.1 | 35.9 | GO:0032451 | demethylase activity(GO:0032451) |
5.1 | 187.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
5.1 | 5.1 | GO:0045182 | translation regulator activity(GO:0045182) |
5.0 | 1046.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
5.0 | 854.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
5.0 | 50.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
5.0 | 45.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
5.0 | 250.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
5.0 | 154.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
5.0 | 19.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
5.0 | 224.0 | GO:0000149 | SNARE binding(GO:0000149) |
5.0 | 64.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
5.0 | 84.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
5.0 | 9.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
5.0 | 163.4 | GO:0042562 | hormone binding(GO:0042562) |
4.9 | 44.5 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
4.9 | 19.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
4.9 | 98.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
4.9 | 4.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
4.9 | 4.9 | GO:0008061 | chitin binding(GO:0008061) |
4.8 | 150.2 | GO:0015923 | mannosidase activity(GO:0015923) |
4.8 | 130.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
4.8 | 24.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
4.8 | 19.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
4.8 | 9.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
4.8 | 243.4 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
4.8 | 142.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
4.8 | 9.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
4.7 | 61.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
4.7 | 56.8 | GO:0090484 | drug transporter activity(GO:0090484) |
4.7 | 89.6 | GO:0043621 | protein self-association(GO:0043621) |
4.7 | 47.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
4.7 | 51.6 | GO:0004175 | endopeptidase activity(GO:0004175) |
4.7 | 46.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
4.7 | 4.7 | GO:0019863 | IgE binding(GO:0019863) |
4.6 | 13.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
4.6 | 13.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
4.6 | 51.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
4.6 | 92.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
4.6 | 18.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
4.6 | 4.6 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
4.6 | 13.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
4.6 | 23.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
4.6 | 18.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
4.6 | 4.6 | GO:0051213 | dioxygenase activity(GO:0051213) |
4.6 | 22.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
4.6 | 2434.2 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
4.6 | 18.3 | GO:0070513 | death domain binding(GO:0070513) |
4.6 | 500.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
4.5 | 117.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
4.5 | 121.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
4.5 | 18.0 | GO:0048038 | quinone binding(GO:0048038) |
4.5 | 4.5 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
4.4 | 17.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
4.4 | 8.9 | GO:0005534 | galactose binding(GO:0005534) |
4.4 | 35.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
4.4 | 22.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
4.4 | 13.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
4.4 | 4.4 | GO:0034452 | dynactin binding(GO:0034452) |
4.4 | 8.8 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
4.4 | 17.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
4.4 | 39.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
4.4 | 13.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
4.3 | 30.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
4.3 | 43.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
4.3 | 4.3 | GO:0019862 | IgA binding(GO:0019862) |
4.3 | 8.5 | GO:0015250 | water channel activity(GO:0015250) |
4.3 | 4.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
4.2 | 42.3 | GO:0070888 | E-box binding(GO:0070888) |
4.2 | 126.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
4.2 | 46.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
4.2 | 25.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
4.2 | 4.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
4.2 | 12.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
4.2 | 20.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
4.2 | 16.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
4.2 | 183.6 | GO:0016791 | phosphatase activity(GO:0016791) |
4.2 | 4.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
4.2 | 4.2 | GO:0016015 | morphogen activity(GO:0016015) |
4.1 | 29.0 | GO:0031491 | nucleosome binding(GO:0031491) |
4.1 | 24.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
4.1 | 102.9 | GO:0016887 | ATPase activity(GO:0016887) |
4.1 | 834.3 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
4.1 | 8.2 | GO:0009975 | cyclase activity(GO:0009975) |
4.1 | 20.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
4.1 | 164.1 | GO:0001047 | core promoter binding(GO:0001047) |
4.1 | 352.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
4.1 | 16.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
4.0 | 60.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
4.0 | 8.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
4.0 | 16.0 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
4.0 | 16.0 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
4.0 | 307.3 | GO:0003774 | motor activity(GO:0003774) |
4.0 | 79.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
4.0 | 39.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
4.0 | 110.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
4.0 | 19.8 | GO:0005319 | lipid transporter activity(GO:0005319) |
3.9 | 11.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
3.9 | 11.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
3.9 | 11.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
3.9 | 38.8 | GO:0042805 | actinin binding(GO:0042805) |
3.8 | 72.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
3.8 | 462.6 | GO:0003723 | RNA binding(GO:0003723) |
3.8 | 41.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
3.8 | 3.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
3.8 | 7.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
3.7 | 223.0 | GO:0003712 | transcription cofactor activity(GO:0003712) |
3.7 | 25.9 | GO:0003796 | lysozyme activity(GO:0003796) |
3.7 | 3.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
3.7 | 7.4 | GO:0043199 | sulfate binding(GO:0043199) |
3.7 | 22.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
3.7 | 43.8 | GO:0004386 | helicase activity(GO:0004386) |
3.6 | 3.6 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
3.6 | 36.3 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
3.6 | 54.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
3.6 | 139.5 | GO:0042393 | histone binding(GO:0042393) |
3.5 | 24.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
3.5 | 35.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
3.5 | 292.2 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
3.5 | 1126.6 | GO:0042802 | identical protein binding(GO:0042802) |
3.5 | 41.4 | GO:0042578 | phosphoric ester hydrolase activity(GO:0042578) |
3.4 | 41.3 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
3.4 | 153.5 | GO:0005262 | calcium channel activity(GO:0005262) |
3.4 | 346.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
3.4 | 6.8 | GO:0015643 | toxic substance binding(GO:0015643) |
3.4 | 6.8 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
3.3 | 53.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
3.3 | 19.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
3.3 | 23.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
3.3 | 3.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
3.2 | 54.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
3.2 | 19.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
3.2 | 389.5 | GO:0019900 | kinase binding(GO:0019900) |
3.2 | 3.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
3.2 | 28.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
3.2 | 6.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
3.1 | 37.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
3.1 | 6.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
3.1 | 43.4 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
3.1 | 21.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
3.0 | 3.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
3.0 | 130.3 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
3.0 | 287.0 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
2.9 | 26.5 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
2.9 | 82.3 | GO:0005496 | steroid binding(GO:0005496) |
2.9 | 137.2 | GO:0046983 | protein dimerization activity(GO:0046983) |
2.9 | 5.8 | GO:0002046 | opsin binding(GO:0002046) |
2.9 | 5.8 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
2.9 | 5.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.9 | 14.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.9 | 80.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.8 | 22.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
2.8 | 5.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
2.8 | 19.6 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
2.8 | 16.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.8 | 22.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
2.7 | 71.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
2.7 | 10.9 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
2.7 | 455.9 | GO:0005525 | GTP binding(GO:0005525) |
2.6 | 31.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
2.6 | 2.6 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
2.6 | 7.8 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
2.6 | 5.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.6 | 13.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
2.6 | 224.9 | GO:0019904 | protein domain specific binding(GO:0019904) |
2.6 | 10.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
2.5 | 7.6 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
2.5 | 2.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
2.5 | 196.3 | GO:0003682 | chromatin binding(GO:0003682) |
2.5 | 42.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
2.5 | 7.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
2.4 | 2.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
2.4 | 2.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
2.4 | 12.1 | GO:0061134 | peptidase regulator activity(GO:0061134) |
2.4 | 7.2 | GO:0035326 | enhancer binding(GO:0035326) |
2.4 | 333.8 | GO:0046872 | metal ion binding(GO:0046872) |
2.4 | 7.1 | GO:0016209 | antioxidant activity(GO:0016209) |
2.4 | 283.6 | GO:0005509 | calcium ion binding(GO:0005509) |
2.4 | 4.7 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
2.3 | 18.7 | GO:0005272 | sodium channel activity(GO:0005272) |
2.3 | 9.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.3 | 20.9 | GO:0051117 | ATPase binding(GO:0051117) |
2.3 | 4.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
2.3 | 18.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
2.3 | 1187.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
2.2 | 4.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
2.2 | 2.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
2.2 | 24.1 | GO:0005537 | mannose binding(GO:0005537) |
2.2 | 21.8 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
2.2 | 169.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
2.2 | 4.3 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
2.1 | 38.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.1 | 4.2 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
2.1 | 2.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
2.0 | 2.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
2.0 | 6.1 | GO:0019842 | vitamin binding(GO:0019842) |
2.0 | 59.6 | GO:0020037 | heme binding(GO:0020037) |
2.0 | 277.1 | GO:0017171 | serine hydrolase activity(GO:0017171) |
2.0 | 413.0 | GO:0008270 | zinc ion binding(GO:0008270) |
1.9 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.9 | 16.9 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
1.9 | 7.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.8 | 133.5 | GO:0005524 | ATP binding(GO:0005524) |
1.8 | 3.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.8 | 102.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
1.8 | 28.8 | GO:0008134 | transcription factor binding(GO:0008134) |
1.8 | 7.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
1.8 | 33.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
1.7 | 48.9 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
1.7 | 1.7 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
1.7 | 5.2 | GO:0003823 | antigen binding(GO:0003823) |
1.7 | 11.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.7 | 1.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.7 | 151.7 | GO:0005550 | pheromone binding(GO:0005550) |
1.7 | 2734.2 | GO:0005515 | protein binding(GO:0005515) |
1.6 | 1.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.6 | 6.5 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
1.6 | 25.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
1.6 | 1.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.5 | 15.3 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
1.5 | 1.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.4 | 31.4 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
1.4 | 2.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.4 | 1.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.4 | 10.9 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
1.3 | 103.3 | GO:0008289 | lipid binding(GO:0008289) |
1.3 | 5.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.3 | 3.9 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
1.3 | 28.6 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
1.3 | 1.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.3 | 1.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
1.2 | 2.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.2 | 1.2 | GO:0015927 | trehalase activity(GO:0015927) |
1.2 | 1.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.2 | 1297.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
1.0 | 3.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.0 | 24.3 | GO:0000166 | nucleotide binding(GO:0000166) nucleoside phosphate binding(GO:1901265) |
0.9 | 13.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.9 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.8 | 2.4 | GO:0008509 | anion transmembrane transporter activity(GO:0008509) |
0.8 | 9.3 | GO:0016247 | channel regulator activity(GO:0016247) |
0.6 | 116.6 | GO:0004871 | signal transducer activity(GO:0004871) |
0.5 | 34.7 | GO:0005215 | transporter activity(GO:0005215) |
0.5 | 2.9 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.5 | 0.9 | GO:0008144 | drug binding(GO:0008144) |
0.4 | 9.7 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.4 | 37.8 | GO:0005198 | structural molecule activity(GO:0005198) |
0.4 | 1.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.2 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
34.9 | 488.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
27.5 | 826.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
27.0 | 296.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
19.4 | 77.4 | ST STAT3 PATHWAY | STAT3 Pathway |
18.8 | 470.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
18.7 | 615.7 | PID ARF6 PATHWAY | Arf6 signaling events |
18.5 | 443.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
17.7 | 194.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
16.6 | 199.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
16.5 | 990.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
16.4 | 82.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
16.2 | 129.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
16.1 | 80.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
16.0 | 415.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
15.5 | 216.3 | PID IGF1 PATHWAY | IGF1 pathway |
14.9 | 133.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
14.8 | 191.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
14.7 | 132.4 | PID EPO PATHWAY | EPO signaling pathway |
14.6 | 248.9 | PID ARF 3PATHWAY | Arf1 pathway |
14.6 | 43.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
14.5 | 320.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
14.4 | 158.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
13.9 | 320.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
13.9 | 332.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
13.7 | 425.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
13.7 | 370.1 | PID RHOA PATHWAY | RhoA signaling pathway |
13.4 | 13.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
13.4 | 401.6 | PID ATR PATHWAY | ATR signaling pathway |
12.8 | 256.3 | PID AURORA A PATHWAY | Aurora A signaling |
12.8 | 589.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
12.7 | 698.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
12.6 | 339.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
12.4 | 62.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
12.3 | 24.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
12.1 | 289.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
12.0 | 132.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
11.9 | 417.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
11.9 | 570.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
11.9 | 47.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
11.7 | 23.5 | ST GAQ PATHWAY | G alpha q Pathway |
11.6 | 46.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
11.1 | 78.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
10.7 | 117.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
10.7 | 10.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
10.5 | 146.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
10.3 | 351.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
10.2 | 50.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
10.2 | 111.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
10.1 | 80.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
10.0 | 90.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
10.0 | 79.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
9.9 | 248.7 | PID PLK1 PATHWAY | PLK1 signaling events |
9.9 | 89.0 | PID BARD1 PATHWAY | BARD1 signaling events |
9.8 | 107.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
9.6 | 133.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
9.5 | 294.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
9.5 | 161.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
9.4 | 150.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
9.3 | 102.1 | PID IFNG PATHWAY | IFN-gamma pathway |
9.2 | 73.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
9.2 | 45.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
9.2 | 605.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
9.0 | 171.8 | PID FOXO PATHWAY | FoxO family signaling |
8.9 | 26.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
8.8 | 396.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
8.8 | 26.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
8.6 | 120.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
8.6 | 284.1 | PID E2F PATHWAY | E2F transcription factor network |
8.5 | 93.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
8.5 | 136.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
8.5 | 110.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
8.4 | 185.8 | PID LKB1 PATHWAY | LKB1 signaling events |
8.4 | 100.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
8.2 | 57.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
8.1 | 40.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
8.0 | 56.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
8.0 | 152.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
8.0 | 120.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
8.0 | 16.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
8.0 | 183.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
7.9 | 71.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
7.8 | 117.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
7.8 | 38.8 | PID ATM PATHWAY | ATM pathway |
7.7 | 84.2 | PID CDC42 PATHWAY | CDC42 signaling events |
7.7 | 107.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
7.3 | 146.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
7.2 | 108.0 | PID P53 REGULATION PATHWAY | p53 pathway |
6.9 | 125.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
6.8 | 13.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
6.7 | 40.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
6.7 | 141.0 | PID AURORA B PATHWAY | Aurora B signaling |
6.6 | 13.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
6.5 | 98.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
6.5 | 32.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
6.5 | 135.8 | PID P73PATHWAY | p73 transcription factor network |
6.5 | 64.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
6.4 | 51.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
6.3 | 107.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
6.2 | 18.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
6.2 | 210.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
6.1 | 128.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
5.9 | 64.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
5.8 | 58.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
5.8 | 17.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
5.6 | 50.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
5.6 | 156.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
5.6 | 5.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
5.5 | 60.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
5.4 | 37.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
5.3 | 89.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
5.2 | 103.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
5.1 | 35.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
5.0 | 25.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
4.8 | 62.7 | PID RAS PATHWAY | Regulation of Ras family activation |
4.8 | 85.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
4.7 | 23.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
4.7 | 28.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
4.5 | 4.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
4.3 | 21.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
4.3 | 64.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
4.3 | 55.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
4.2 | 193.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
4.2 | 54.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
4.1 | 28.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
4.1 | 8.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
3.9 | 34.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
3.8 | 34.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
3.8 | 26.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
3.7 | 44.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
3.6 | 10.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
3.6 | 678.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
3.6 | 42.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
3.4 | 10.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
3.4 | 27.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
3.4 | 41.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
3.4 | 13.6 | PID ALK2 PATHWAY | ALK2 signaling events |
3.4 | 30.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
3.3 | 20.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
3.3 | 26.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
3.3 | 6.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
3.3 | 32.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
3.1 | 40.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
3.1 | 18.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
2.9 | 5.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
2.7 | 361.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
2.6 | 26.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
2.6 | 41.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
2.5 | 5.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
2.5 | 24.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
2.3 | 23.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
2.3 | 58.0 | PID BMP PATHWAY | BMP receptor signaling |
2.3 | 18.6 | PID BCR 5PATHWAY | BCR signaling pathway |
2.3 | 29.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
2.3 | 11.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.3 | 6.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
2.1 | 19.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.9 | 11.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.9 | 11.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.8 | 3.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.8 | 1.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.7 | 3.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.7 | 6.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.6 | 9.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.6 | 11.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.5 | 11.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.3 | 6.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.2 | 9.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.2 | 13.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.2 | 207.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
1.1 | 2.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.1 | 13.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.0 | 1.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.9 | 0.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.7 | 112.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
66.3 | 927.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
53.0 | 635.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
48.9 | 489.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
45.0 | 449.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
43.5 | 391.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
34.9 | 34.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
34.2 | 376.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
33.5 | 100.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
33.1 | 562.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
31.9 | 255.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
30.8 | 307.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
28.9 | 434.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
28.8 | 28.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
28.5 | 342.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
28.2 | 225.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
26.7 | 186.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
26.3 | 263.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
24.3 | 97.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
22.3 | 513.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
22.3 | 178.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
22.1 | 154.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
21.6 | 86.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
19.8 | 535.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
19.8 | 158.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
19.5 | 175.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
18.8 | 169.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
18.7 | 393.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
18.5 | 332.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
18.0 | 72.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
17.7 | 673.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
17.5 | 244.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
17.2 | 344.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
17.2 | 257.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
17.1 | 188.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
17.1 | 291.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
16.9 | 67.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
16.8 | 100.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
16.2 | 97.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
15.9 | 461.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
15.9 | 111.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
15.7 | 392.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
15.5 | 200.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
15.4 | 416.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
15.3 | 45.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
15.3 | 45.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
15.2 | 213.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
15.2 | 213.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
15.1 | 166.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
15.0 | 676.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
15.0 | 403.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
14.9 | 148.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
14.7 | 219.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
14.4 | 114.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
14.2 | 184.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
14.2 | 85.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
14.1 | 127.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
14.1 | 42.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
14.0 | 308.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
14.0 | 153.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
13.6 | 13.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
13.5 | 406.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
13.5 | 27.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
13.5 | 94.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
13.5 | 188.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
13.4 | 120.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
13.4 | 173.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
13.3 | 106.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
13.2 | 290.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
13.2 | 52.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
13.1 | 196.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
13.0 | 325.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
12.8 | 653.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
12.8 | 369.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
12.6 | 37.9 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
12.5 | 374.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
12.3 | 503.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
12.2 | 12.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
12.2 | 972.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
12.1 | 278.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
12.1 | 60.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
12.1 | 144.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
11.9 | 11.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
11.7 | 35.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
11.7 | 58.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
11.6 | 69.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
11.5 | 23.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
11.5 | 92.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
11.4 | 262.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
11.3 | 22.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
11.3 | 11.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
11.3 | 11.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
11.2 | 280.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
11.2 | 55.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
11.1 | 211.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
11.1 | 122.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
11.0 | 308.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
10.9 | 328.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
10.9 | 119.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
10.8 | 53.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
10.8 | 183.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
10.7 | 21.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
10.7 | 107.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
10.6 | 170.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
10.6 | 190.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
10.5 | 10.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
10.5 | 231.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
10.5 | 231.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
10.5 | 84.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
10.5 | 104.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
10.2 | 81.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
10.1 | 60.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
10.1 | 10.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
10.1 | 596.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
10.1 | 181.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
10.0 | 338.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
10.0 | 109.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
10.0 | 567.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
9.9 | 138.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
9.8 | 108.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
9.7 | 9.7 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
9.6 | 124.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
9.4 | 9.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
9.3 | 204.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
9.1 | 73.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
9.1 | 72.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
9.1 | 99.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
9.0 | 81.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
9.0 | 45.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
9.0 | 483.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
8.8 | 52.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
8.8 | 123.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
8.7 | 96.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
8.7 | 445.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
8.5 | 136.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
8.5 | 271.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
8.5 | 50.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
8.4 | 226.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
8.2 | 155.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
8.1 | 48.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
8.1 | 161.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
8.1 | 88.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
8.1 | 64.4 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
8.0 | 263.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
7.9 | 103.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
7.9 | 23.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
7.9 | 70.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
7.8 | 46.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
7.7 | 61.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
7.7 | 38.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
7.7 | 199.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
7.6 | 38.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
7.5 | 900.8 | REACTOME TRANSLATION | Genes involved in Translation |
7.5 | 29.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
7.4 | 73.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
7.4 | 51.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
7.2 | 7.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
7.2 | 72.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
7.2 | 36.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
7.2 | 7.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
7.2 | 71.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
7.2 | 271.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
7.1 | 77.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
7.1 | 7.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
7.0 | 77.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
7.0 | 530.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
6.9 | 27.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
6.9 | 110.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
6.9 | 179.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
6.9 | 68.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
6.8 | 191.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
6.7 | 777.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
6.7 | 53.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
6.6 | 106.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
6.6 | 604.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
6.5 | 71.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
6.5 | 51.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
6.4 | 6.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
6.2 | 43.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
6.1 | 61.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
6.1 | 36.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
6.0 | 144.2 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
5.9 | 41.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
5.9 | 17.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
5.6 | 16.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
5.6 | 61.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
5.6 | 33.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
5.6 | 111.5 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
5.6 | 61.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
5.5 | 60.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
5.5 | 93.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
5.4 | 43.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
5.4 | 135.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
5.4 | 48.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
5.4 | 225.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
5.3 | 42.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
5.3 | 73.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
5.2 | 26.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
5.2 | 327.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
5.1 | 15.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
5.1 | 127.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
5.1 | 71.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
5.1 | 35.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
5.0 | 55.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
5.0 | 34.7 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
4.9 | 14.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
4.8 | 58.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
4.7 | 52.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
4.7 | 9.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
4.6 | 13.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
4.5 | 184.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
4.4 | 8.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
4.4 | 175.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
4.1 | 66.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
4.1 | 49.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
4.0 | 67.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
3.9 | 74.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
3.8 | 3.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
3.8 | 57.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
3.8 | 26.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
3.8 | 71.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
3.8 | 33.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
3.7 | 138.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
3.7 | 11.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.6 | 21.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
3.6 | 39.6 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
3.6 | 49.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
3.5 | 20.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
3.4 | 13.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
3.4 | 13.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
3.4 | 44.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
3.4 | 71.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
3.4 | 23.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
3.3 | 3.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
3.3 | 16.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
3.2 | 9.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
3.2 | 35.3 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
3.2 | 19.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
3.1 | 44.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
3.1 | 37.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
3.1 | 6.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
3.1 | 3.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
3.0 | 304.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
2.9 | 23.5 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
2.9 | 17.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
2.8 | 13.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
2.8 | 16.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
2.7 | 13.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
2.7 | 38.4 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
2.7 | 21.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
2.6 | 150.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
2.5 | 25.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
2.4 | 2.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
2.4 | 33.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
2.4 | 30.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
2.3 | 6.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
2.3 | 2.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
2.2 | 8.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.9 | 14.8 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
1.8 | 26.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
1.8 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.8 | 67.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.6 | 8.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.5 | 52.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
1.4 | 28.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
1.4 | 6.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.3 | 2.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.3 | 1.3 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
1.1 | 1.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.1 | 17.6 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
1.1 | 2.2 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
1.0 | 12.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.0 | 3.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.0 | 2.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.0 | 1.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.9 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.8 | 9.9 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.8 | 3.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.8 | 0.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.8 | 1.6 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.8 | 3.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.7 | 0.7 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.7 | 10.6 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.7 | 7.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 21.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 12.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.5 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 5.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.3 | 2.4 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.3 | 4.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 3.0 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |